EX-99.1

Exhibit(cid:160)99.1

FEDERAL DEPOSIT INSURANCE CORPORATION

WASHINGTON, D. C. 20429

FORM 10-Q

(cid:160)

(cid:160) (cid:160) (cid:160)
þ (cid:160) Quarterly Report Pursuant to Section(cid:160)13 or 15(d) of the Securities Exchange Act

of 1934

(cid:160)
(cid:160) (cid:160) For the quarterly period ended September(cid:160)30, 2010

(cid:160) (cid:160) (cid:160)
o (cid:160) Transition Report Pursuant to Section(cid:160)13 or 15(d) of the Securities Exchange Act

of 1934

For the transition period from 

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)

 to 

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)

FDIC Certificate Number 58408

PARK STERLING BANK

(Exact name of registrant as specified in its charter)

(cid:160)

NORTH CAROLINA
(State or Other Jurisdiction of
Incorporation or Organization)

(cid:160) (cid:160)

(cid:160) 20-5560515

(I.R.S. Employer Identification No.)

EX-99.1

POWERED BY DOCRACY.COM

1

 of 

98

(cid:160)

(cid:160) (cid:160)

1043 E. Morehead Street, Suite(cid:160)201
Charlotte, North Carolina
(Address of Principal Executive Offices)
Registrants telephone number, including area code: (704)(cid:160)716-2134

(cid:160) 28204

(Zip Code)

Former name, former address and former fiscal year, if changed since last report: Not
applicable

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Indicate by check mark whether the registrant (1)(cid:160)has filed all reports required to be filed by
Section(cid:160)13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12(cid:160)months (or
for such shorter period that the Registrant was required to file such reports), and (2)(cid:160)has been
subject to such filing requirements for the past 90(cid:160)days. Yes þ No o

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule(cid:160)405 of Regulation(cid:160)S-T (Section(cid:160)232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes o No o

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer,
accelerated filer and smaller reporting company in Rule12b-2 of the Exchange Act). (Check one)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) Accelerated

company þ

Filer o

smaller reporting company)

(cid:160) Non-accelerated filer o (Do not check if a

Large
accelerated
filer o
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Indicate by check mark whether the registrant is a shell company (as defined in Rule(cid:160)12b-2
of the Exchange Act). Yes o No þ

(cid:160) Smaller reporting

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)As of November(cid:160)8, 2010, the registrant had outstanding 28,051,098 shares of Common
Stock, par value $4.65 per share.

(cid:160)
Table of Contents

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

2

 of 

98

(cid:160)

Part I. FINANCIAL INFORMATION

(cid:160)

Item(cid:160)1. Condensed Financial Statements

(cid:160)

Condensed Balance Sheets September(cid:160)30, 2010 and December(cid:160)31, 2009

(cid:160)

Condensed Statements of Income (Loss) Three Months and Nine Months Ended
September(cid:160)30, 2010 and 2009

(cid:160)

Condensed Statements of Changes in Stockholders Equity Nine Months Ended
September(cid:160)30, 2010 and 2009

(cid:160)

Condensed Statements of Cash Flows Nine Months Ended September(cid:160)30, 2010
and 2009

(cid:160)

Notes to Condensed Financial Statements

(cid:160)

Item(cid:160)2. Managements Discussion and Analysis of Financial Condition
and Results of Operations

(cid:160)

Item(cid:160)3. Quantitative and Qualitative Disclosures about Market Risk

(cid:160)

Item(cid:160)4. Controls and Procedures

(cid:160)

(cid:160)

(cid:160) Page
No.

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

2 (cid:160)

(cid:160) (cid:160)

3 (cid:160)

(cid:160) (cid:160)

4 (cid:160)

(cid:160) (cid:160)

5 (cid:160)

(cid:160) (cid:160)

6 (cid:160)

(cid:160) (cid:160)

22 (cid:160)

(cid:160) (cid:160)

39 (cid:160)

(cid:160) (cid:160)

39 (cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

3

 of 

98

(cid:160) (cid:160)

(cid:160) (cid:160)

39 (cid:160)

(cid:160) (cid:160)

39 (cid:160)

(cid:160) (cid:160)

39 (cid:160)

(cid:160) (cid:160)

39 (cid:160)

(cid:160) (cid:160)

39 (cid:160)

(cid:160) (cid:160)

39 (cid:160)

(cid:160) (cid:160)

40 (cid:160)

(cid:160)

Part II. OTHER INFORMATION

(cid:160)

Item(cid:160)1. Legal Proceedings

(cid:160)

Item(cid:160)1A. Risk Factors

(cid:160)

Item(cid:160)2. Unregistered Sales of Equity Securities and Use of Proceeds

(cid:160)

Item(cid:160)3. Defaults Upon Senior Securities

(cid:160)

Item(cid:160)4. [Removed and Reserved]

(cid:160)

Item(cid:160)5. Other Information

(cid:160)

Item 6. Exhibits

1

(cid:160)
Part(cid:160)I. FINANCIAL INFORMATION
Item(cid:160)1. Condensed Financial Statements

PARK STERLING BANK
CONDENSED BALANCE SHEETS

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)
(cid:160)
(cid:160)

(cid:160)

(cid:160) (cid:160)
(cid:160)
(cid:160) September 30, (cid:160)
(cid:160) 2010
(cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) December

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160)

31,

(cid:160) (Unaudited)

(cid:160)

(cid:160) 2009 *

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

4

 of 

98

(cid:160)

ASSETS

Cash and due from banks

(cid:160) (Dollars in
thousands)

(cid:160) (cid:160)

(cid:160) $

Interest-earning balances at banks

(cid:160) (cid:160)

Federal funds sold

Investment securities
available-for-sale, at fair value

Loans

Allowance for loan losses

(cid:160)

Net loans

(cid:160)

Federal Home Loan Bank stock

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Bank premises and equipment, net (cid:160) (cid:160)

Accrued interest receivable

Other real estate owned

Other assets

(cid:160)

Total assets

(cid:160)

LIABILITIES AND
STOCKHOLDERS EQUITY

(cid:160)

Deposits:

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

11,591

5,859

96,560

115,357

397,658

(13,150

(cid:160)

384,508

(cid:160)

1,825

4,574

1,732

1,441

9,183

(cid:160)

632,630

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

5

 of 

98

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

)

(cid:160) (cid:160)

$ 6,504

(cid:160) 2,758

(cid:160) 13,975

(cid:160) 42,567

(cid:160) 397,564

(cid:160) (7,402

(cid:160)

(cid:160) 390,162

(cid:160)

(cid:160)

(cid:160) 1,896

(cid:160) 4,665

(cid:160) 1,614

(cid:160) 1,550

(cid:160) 8,164

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

$ 473,855

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

Noninterest-bearing demand
deposits

(cid:160) $

30,468

(cid:160) (cid:160)

$ 24,085

Money market, NOW and savings
deposits

(cid:160) (cid:160)

72,639

(cid:160) (cid:160)

(cid:160) 52,308

Time deposits of less than
$100,000

(cid:160) (cid:160)

79,046

(cid:160) (cid:160)

(cid:160) 76,456

Time deposits of $100,000 through
$250,000

(cid:160) (cid:160)

77,998

(cid:160) (cid:160)

(cid:160) 65,551

Time deposits of more than
$250,000

(cid:160)

Total deposits

(cid:160)

Short-term borrowings

Long-term borrowings

Subordinated debt

Accrued interest payable

Accrued expenses and other
liabilities

(cid:160)

Total liabilities

(cid:160)

Stockholders equity:

Preferred stock, no par value

Common stock, $4.65 par value

Additional paid-in capital

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

156,998

(cid:160) (cid:160)

(cid:160) 174,233

(cid:160)

417,149

(cid:160)

1,100

20,000

6,895

282

3,357

(cid:160)

448,783

(cid:160)

(cid:160)

130,438

56,778

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) 392,633

(cid:160) (cid:160)

(cid:160) 6,989

(cid:160) 20,000

(cid:160) 6,895

(cid:160) 436

(cid:160) 807

(cid:160)

(cid:160) 427,760

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) 23,023

(cid:160) 23,496

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

6

 of 

98

Accumulated deficit

Accumulated other comprehensive
income

(cid:160)

Total stockholders equity

(cid:160)

Total liabilities and stockholders
equity

(cid:160)

Preferred shares authorized

Preferred shares issued and
outstanding

Common shares authorized

Common shares issued and
outstanding

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(4,981

1,612

(cid:160)

183,847

(cid:160)

632,630

(cid:160)

) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (1,642

(cid:160) 1,218

)

(cid:160)

(cid:160)

(cid:160) 46,095

(cid:160)

(cid:160)

$ 473,855

(cid:160)

(cid:160)

5,000,000

(cid:160) (cid:160)

(cid:160) 5,000,000 (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

200,000,000 (cid:160) (cid:160)

(cid:160) 45,000,000 (cid:160)

28,051,098 (cid:160) (cid:160)

(cid:160) 4,951,098 (cid:160)

(cid:160) Derived from audited financial statements.

*
The accompanying Notes are an integral part of these Condensed Financial Statements.

2

(cid:160)
PARK STERLING BANK
CONDENSED STATEMENTS OF INCOME (LOSS)
(Unaudited)
(Dollars in thousands, except per share data)

(cid:160)
(cid:160)

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Three

Months
Ended

(cid:160) (cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Nine

Months
Ended

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

7

 of 

98

(cid:160)

(cid:160) September

(cid:160)

(cid:160) September

(cid:160)

30,

(cid:160) 2010
(cid:160) (cid:160)

(cid:160)
(cid:160)

30,

(cid:160) 2009
(cid:160) (cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)

2010 (cid:160) (cid:160) 2009
(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) $

4,963

(cid:160) (cid:160)

$ 5,061

(cid:160)
Interest income

Loans, including
fees

(cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $ 15,275

(cid:160) (cid:160) 60

(cid:160) (cid:160) 981

(cid:160) (cid:160) 481

(cid:160) (cid:160)

(cid:160) (cid:160) 51

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 16,848

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 276

(cid:160) (cid:160) 4,434

(cid:160) (cid:160) 9

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) 423

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

Federal funds sold

(cid:160) (cid:160)

Taxable investment
securities

(cid:160) (cid:160)

Tax-exempt
investment
securities

Interest on deposits
at banks

(cid:160)

Total interest
income

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Interest expense

(cid:160) (cid:160)

42

370

161

23

(cid:160)

5,559

(cid:160)

(cid:160)

(cid:160)

Money market,
NOW and savings
deposits

Time deposits

Short-term
borrowings

Long-term
borrowings

(cid:160) (cid:160)

104

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

1,490

1

144

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) 16

(cid:160) 323

(cid:160) 160

(cid:160) 8

(cid:160) (cid:160)

(cid:160) 5,568

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) 86

(cid:160) 1,860

(cid:160) 6

(cid:160) 143

EX-99.1

POWERED BY DOCRACY.COM

8

 of 

98

Subordinated debt

(cid:160) (cid:160)

(cid:160)

Total interest
expense

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Net interest income (cid:160) (cid:160)

Provision for loan
losses

(cid:160)

Net interest income
(loss)(cid:160)after
provision for loan
losses

(cid:160)

Noninterest
income

Service charges on
deposit accounts

Gain on sale of
securities
available-for-sale

Other than
temporary securities
impairment loss

Other noninterest
income

(cid:160)

Total noninterest
income (loss)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

190

(cid:160)

1,929

(cid:160)

3,630

6,143

(cid:160)

(2,513

(cid:160)

(cid:160)

18

8

(cid:160)

26

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) 188

(cid:160) (cid:160)

(cid:160) 2,283

(cid:160) (cid:160)

(cid:160) 3,285

(cid:160) 1,150

(cid:160) (cid:160)

(cid:160) 2,135

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) 11

(cid:160)

(cid:160)

(cid:160) 15

(cid:160) (cid:160)

(cid:160) 26

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) 569

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 5,711

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 11,137

(cid:160) (cid:160) 8,768

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 2,369

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 47

(cid:160) (cid:160) 19

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) 22

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 88

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

9

 of 

98

(cid:160)

(cid:160)

Noninterest
expense

Salaries and
employee benefits

Occupancy and
equipment

Advertising and
promotion

Legal and
professional fees

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Deposit charges and
FDIC insurance

(cid:160) (cid:160)

Data processing and
outside service fees

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Director fees

Other real estate
owned expense

Other noninterest
expense

(cid:160)

Total noninterest
expense

(cid:160)

Income
(loss)(cid:160)before
income taxes

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

1,777

(cid:160) (cid:160)

(cid:160) 1,182

236

84

78

184

109

164

120

238

(cid:160)

2,990

(cid:160)

(5,477

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

) (cid:160)

(cid:160) 212

(cid:160) 84

(cid:160) 54

(cid:160) 230

(cid:160) 97

(cid:160)

(cid:160) 36

(cid:160) 123

(cid:160) (cid:160)

(cid:160) 2,018

(cid:160) (cid:160)

(cid:160) 143

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) 4,328

(cid:160) (cid:160)

(cid:160) (cid:160) 666

(cid:160) (cid:160)

(cid:160) (cid:160) 237

(cid:160) (cid:160)

(cid:160) (cid:160) 237

(cid:160) (cid:160)

(cid:160) (cid:160) 543

(cid:160) (cid:160)

(cid:160) (cid:160) 302

(cid:160) (cid:160)

(cid:160) (cid:160) 211

(cid:160) (cid:160) 395

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) 591

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 7,510

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (5,053

) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

10

 of 

98

Income tax expense
(benefit)

(cid:160) (cid:160)

(1,809

) (cid:160)

(cid:160) 27

(cid:160)

(cid:160) (cid:160)

(cid:160)

Net income (loss) (cid:160) $

(cid:160)

Basic earnings
(loss)(cid:160)per
common share

(cid:160)

Diluted earnings
(loss)(cid:160)per
common share

(cid:160)

Weighted-average
common shares
outstanding

Basic

(cid:160)

Diluted

(cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

) (cid:160)

(cid:160) (cid:160)

) (cid:160)

(cid:160) (cid:160)

) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

$ 116

(cid:160) (cid:160)

$ 0.02

(cid:160) (cid:160)

$ 0.02

(cid:160) (cid:160)

(cid:160) (cid:160)

(3,668

(cid:160)

(0.23

(cid:160)

(0.23

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (1,714

) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) $ (3,339

) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) $ (0.38

) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) $ (0.38

) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

15,998,924 (cid:160) (cid:160)

(cid:160) 4,951,098 (cid:160)

(cid:160) (cid:160) 8,674,175 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

15,998,924 (cid:160) (cid:160)

(cid:160) 4,951,098 (cid:160)

(cid:160) (cid:160) 8,674,175 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

The accompanying Notes are an integral part of these Condensed Financial Statements.

3

(cid:160)
PARK STERLING BANK
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY
For the Nine Months Ended September(cid:160)30, 2010 and 2009
(Unaudited)
(Dollars in thousands)

EX-99.1

POWERED BY DOCRACY.COM

11

 of 

98

(cid:160)
(cid:160)
(cid:160)
Accumulated (cid:160) (cid:160)

(cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) Additional (cid:160)

(cid:160) Amount (cid:160) (cid:160)

Capital

(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Common

Stock
(cid:160) Shares

(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Paid-In (cid:160) (cid:160)

Balance at
December(cid:160)31,
2008

(cid:160)

Share-based
compensation
expense

(cid:160)

Comprehensive
income (loss):

Net income

Unrealized
holding gains on
available-for-sale
securities, net of
taxes

Unrealized
holding losses
on interest rate
swaps, net of
taxes

(cid:160)

(cid:160)

(cid:160) (cid:160)

4,951,098 (cid:160) (cid:160)

$ 23,023 (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

12

 of 

98

Comprehensive

Deficit

22,854

(cid:160)

499

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

23,353

(cid:160)

(cid:160)

23,496

(cid:160)

32,796

(cid:160)

486

(cid:160)

(cid:160)

Total
comprehensive
income (loss)

(cid:160)

(cid:160)

(cid:160)

Balance at
September(cid:160)30,
2009

(cid:160)

(cid:160)

Balance at
December(cid:160)31,
2009

(cid:160)

Issuance of
common stock,
net of costs

(cid:160)

Share-based
compensation
expense

(cid:160)

Comprehensive
income (loss):

Net loss

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

4,951,098 (cid:160) (cid:160)

$ 23,023 (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

4,951,098 (cid:160) (cid:160)

$ 23,023 (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

23,100,000 (cid:160) (cid:160)

(cid:160) 107,415 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

13

 of 

98

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Unrealized
holding gains on
available-for-sale
securities, net of
taxes

Unrealized
holding losses
on interest rate
swaps, net of
taxes

(cid:160)

(cid:160)

Total
comprehensive
income (loss)

(cid:160)

(cid:160)

(cid:160)

Balance at
September(cid:160)30,
2010

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

28,051,098 (cid:160) (cid:160)

$ 130,438 (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

56,778

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

The accompanying Notes are an integral part of these Condensed Financial Statements.

4

(cid:160)
PARK STERLING BANK
CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in thousands)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

14

 of 

98

(cid:160) Nine Months

(cid:160)

Ended

(cid:160) September

30,

(cid:160) 2010
(cid:160) (cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160) 2009 (cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160)

(3,339

) (cid:160)

$ 459

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

443

(cid:160) (cid:160)

(cid:160) 257

8,768

(cid:160) (cid:160)

(cid:160) 1,854

486

(353

576

(19

342

(cid:160)

(118

(cid:160) (cid:160)

) (cid:160)

(cid:160) (cid:160)

) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

) (cid:160)

(cid:160) 499

(cid:160) (637

(cid:160)

(cid:160) (349

(cid:160) 15

(cid:160) 698

(cid:160) (cid:160)

(cid:160) (208

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

)

(cid:160)

)

(cid:160)

(cid:160)

(cid:160)

)

(2,296

) (cid:160)

(cid:160) (1,369 )

(154

) (cid:160)

(cid:160) (548

2,552

(cid:160) (cid:160)

(cid:160) (514

)

)

(cid:160)

(cid:160) (cid:160)

(cid:160)

6,888

(cid:160) (cid:160)

(cid:160) 157

(cid:160)

(cid:160)

(cid:160)

(cid:160)
Cash flows from operating activities

Net income (loss)

Adjustments to reconcile net income (loss)(cid:160)to net
cash provided by operating activities:

Depreciation and amortization

Provision for loan losses

Stock option expense

Income on termination of swap

Deferred income taxes

Net gains on sales of investment securities
available-for-sale

Net losses on sales of other real estate

Other than temporary securities impairment loss

Change in assets and liabilities:

Increase in accrued interest receivable

Increase in other assets

Decrease in accrued interest payable

Increase (decrease)(cid:160)in accrued expenses and other
liabilities

(cid:160)

Net cash provided by operating activities

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

15

 of 

98

(cid:160)

Cash flows from investing activities

Net increase in loans

Purchases of bank premises and equipment

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(5,963

) (cid:160)

(cid:160) (23,343 )

(169

) (cid:160)

(cid:160) (11

)

Purchases of investment securities available-for-sale (cid:160) (cid:160)

(81,268 ) (cid:160)

(cid:160) (22,813 )

Proceeds from sales of investment securities
available-for-sale

Proceeds from maturities and call of investment
securities available-for-sale

Improvements to other real estate

Proceeds from sale of other real estate

Purchase (redemption)(cid:160)of Federal Home Loan
Bank stock

Purchase of other assets

(cid:160)

Net cash used for investing activities

Cash flows from financing activities

Net increase in deposits

Decrease in short-term borrowings

Proceeds from issuance of subordinated debt

Proceeds from issuance of common stock, net of
costs

(cid:160)

Net cash provided by financing activities

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

2,155

(cid:160) (cid:160)

(cid:160) 11,490 (cid:160)

7,590

(cid:160) (cid:160)

(cid:160) 3,040

(cid:160)

(93

) (cid:160)

(cid:160) (45

2,724

(cid:160) (cid:160)

(cid:160) 1,227

71

(cid:160) (cid:160)

(cid:160) (327

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (65

(cid:160)

(cid:160)

)

(cid:160)

)

)

(74,953 ) (cid:160)

(cid:160) (30,847 )

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

24,516 (cid:160) (cid:160)

(cid:160) 37,912 (cid:160)

)

(cid:160)

(cid:160)

(5,889

) (cid:160)

(cid:160) (806

(cid:160) (cid:160)

(cid:160) 6,895

140,211 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

158,838 (cid:160) (cid:160)

(cid:160) 44,001 (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

16

 of 

98

Net increase in cash and cash equivalents

Cash and cash equivalents, beginning

(cid:160)

Cash and cash equivalents, ending

(cid:160)

(cid:160)

Supplemental disclosures of cash flow
information:

Cash paid for interest

Cash paid for income taxes

(cid:160)

Supplemental disclosure of noncash investing
and financing activities:

Change in unrealized gain on available-for-sale
securities, net of tax

Change in unrealized loss on swap, net of tax

Loans transferred to other real estate owned

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

90,773 (cid:160) (cid:160)

(cid:160) 13,311 (cid:160)

23,237 (cid:160) (cid:160)

(cid:160) 16,511 (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

114,010 (cid:160) (cid:160)

$ 29,822 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

5,865

(cid:160) (cid:160)

$ 7,817

950

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) 1,724

(cid:160) (cid:160)

(cid:160) (cid:160)

888

(cid:160) (cid:160)

$ 444

(494

) (cid:160)

(cid:160) (811

2,864

(cid:160) (cid:160)

(cid:160) 929

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

)

(cid:160)

The accompanying Notes are an integral part of these Condensed Financial Statements.

5

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements
(Unaudited)

Note 1  Basis of Presentation

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Park Sterling Bank (the Bank) was incorporated on September(cid:160)8, 2006 and began banking
operations in October(cid:160)2006. The Bank is engaged in full-service commercial banking in the

EX-99.1

POWERED BY DOCRACY.COM

17

 of 

98

Charlotte and Wilmington regions of North Carolina, operating under the banking laws of North
Carolina and the rules and regulations of the Federal Deposit Insurance Corporation (FDIC)(cid:160)and
the North Carolina Commissioner of Banks.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The accompanying unaudited condensed financial statements and notes have been prepared
in accordance with accounting principles generally accepted in the United States (GAAP) for
interim financial information and the instructions to Form 10-Q and Article(cid:160)10 of
Regulation(cid:160)S-X. Accordingly, they do not include all of the information or footnotes necessary for
a complete presentation of financial position, results of operations and cash flows in conformity
with GAAP. The organization and business of the Bank, accounting policies followed by the Bank
and other information are contained in the notes to the audited financial statements for the year
ended December(cid:160)31, 2009 filed as part of the Banks Registration Statement on Form(cid:160)10 (the
Registration Statement). This quarterly report should be read in conjunction with the Registration
Statement.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In managements opinion, the accompanying unaudited condensed financial statements reflect
all normal, recurring adjustments necessary to present fairly the financial position of the Bank as of
September(cid:160)30, 2010 and December(cid:160)31, 2009, and the results of operations and cash flows for the
three and nine months ended September(cid:160)30, 2010 and 2009. Operating results for the three and
nine month periods ended September(cid:160)30, 2010 are not necessarily indicative of the results that may
be expected for the year ending December(cid:160)31, 2010 or other interim periods.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The preparation of financial statements in conformity with GAAP requires management to
make estimates and assumptions that affect the amounts reported in the condensed financial
statements and accompanying notes. Actual results could differ from those estimates. Material
estimates that are susceptible to significant change in the near term are the valuation of the
allowance for loan losses and the fair value of financial instruments and other accounts.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Certain amounts reported in prior periods have been reclassified to conform to the current
period presentation.

Note 2  Recent Accounting Pronouncements

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In January(cid:160)2010, the Financial Accounting Standards Board (FASB) issued Accounting
Standards Update (ASU) Fair Value Measurements and Disclosures (Topic 820): Improving Disclosures
about Fair Value Measurement
disclosures and clarifies some existing disclosure requirements about fair value measurement as set
forth in FASB Accounting Standards Codification Subtopic 820-10. The FASBs objective is to
improve these disclosures and, thus, increase transparency in financial reporting.

 (ASU No.(cid:160)2010-06). ASU No.(cid:160)2010-06 requires some new

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Specifically, ASU No.(cid:160)2010-06 amends Codification Subtopic 820-10 to now require that:
(1)(cid:160)a reporting entity disclose separately the amounts of significant transfers in and out of Level 1
and Level 2 fair value measurements and describe the reasons for the transfers; and (2)(cid:160)a reporting
entity present separately information about purchases, sales, issuances, and settlements in the

EX-99.1

POWERED BY DOCRACY.COM

18

 of 

98

reconciliation for fair value measurements using significant unobservable inputs (Level 3). In
addition, ASU No.(cid:160)2010-06 clarifies the requirements for purposes of reporting fair value
measurement for each class of assets and liabilities, and that a reporting entity needs to use judgment
in determining the appropriate classes of assets and liabilities and should provide disclosures about
the valuation techniques and inputs used to measure fair value for both recurring and nonrecurring
fair value measurements. ASU No.(cid:160)2010-06 became effective for interim and annual reporting
periods beginning after December(cid:160)15, 2009, except for the disclosures about purchases, sales,
issuances, and settlements in the roll forward of activity in Level 3 fair

6

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

value measurements which are effective for fiscal years beginning after December(cid:160)15, 2010, and for
interim periods within those fiscal years. The adoption of ASU No.(cid:160)2010-06 during the period
ended September(cid:160)30, 2010 resulted in new disclosures.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In February(cid:160)2010, the FASB issued ASU No.(cid:160)2010-09, Subsequent Events (Topic 855):
Amendments to Certain Recognition and Disclosure Requirements
No.(cid:160)2010-09 removes some contradictions between the requirements of GAAP and the rules of
the Securities and Exchange Commission (SEC). SEC filers are required to evaluate subsequent
events through the date the financial statements are issued, and they are no longer required to
disclose the date through which subsequent events have been evaluated. This guidance was
effective upon issuance except for the use of the issued date for conduit debt obligors.

 (ASU No.(cid:160)2010-09). ASU

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In July(cid:160)2010, the FASB issued ASU No.(cid:160)2010-20, Disclosures about the Credit Quality of
Financing Receivables and the Allowance for Credit Losses (Topic 310)
 (ASU No.(cid:160)2010-20). ASU
No.(cid:160)2010-20 will require the Bank to provide a greater level of disaggregated information about
the credit quality of the Banks loans and the Allowance for Loan Losses (the Allowance). ASU No.
2010-20 will also require the Bank to disclose additional information related to credit quality
indicators, past due information, and information related to loans modified in a troubled debt
restructuring. The provisions of ASU No.(cid:160)2010-20 are effective for the Banks reporting period
ending December(cid:160)31, 2010. As this ASU amends only the disclosure requirements for loans and
the Allowance, the adoption will have no material impact on the Banks financial condition.

Note 3  Stockholders Equity

Common Stock

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)On May(cid:160)4, 2010, stockholders approved an amendment to the Articles of Incorporation of
the Bank to increase the number of authorized shares of common stock to 200,000,000.

EX-99.1

POWERED BY DOCRACY.COM

19

 of 

98

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)On August(cid:160)18, 2010, in connection with its initial public offering, the Bank consummated
the issuance and sale of 23,100,000 shares of common stock at $6.50 per share, for a gross aggregate
offering price of $150.2(cid:160)million. The Bank incurred underwriting fees of $6.0(cid:160)million and related
expenses of $0.9(cid:160)million resulting in net proceeds of $143.2(cid:160)million being received by the Bank of
which $140.2 was recorded in stockholders equity. Additional underwriting fees equal to $3.0
million will be payable in the future if the Banks common stock price closes at a price equal to or
above 125% of the offering price, or $8.125 per share, for a period of 30 consecutive days. A
liability for the $3.0(cid:160)million contingent underwriting fees has been accrued and is included in other
liabilities in the accompanying balance sheet at September(cid:160)30, 2010.

Share-Based Plans

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The Bank maintains equity-based compensation plans for directors and employees. Detailed
descriptions of the 2006 option plans are included in Note N to the Banks audited financial
statements included in the Registration Statement. In July(cid:160)2010, the board of directors adopted the
Park Sterling Bank 2010 Stock Option Plan for Directors and the Park Sterling Bank 2010
Employee Stock Option Plan (the 2010 Plans). The 2010 Plans are substantially similar to the
existing option plans for directors and employees and are subject to stockholder approval at the
special stockholders meeting to be held on November(cid:160)23, 2010 and to the approval of the North
Carolina Commissioner of Banks. Pursuant to the 2010 Employee Stock Option Plan, 1,593,900
shares of common stock are reserved for issuance and 265,650 shares of common stock are reserved
for issuance pursuant to the 2010 Stock Option Plan for Directors.

7

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Activity in the Banks stock option plans is summarized in the following table:

Stock Option Activity

EX-99.1

POWERED BY DOCRACY.COM

20

 of 

98

(cid:160)
(cid:160)
(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) Shares (cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Price (cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)
Weighted- (cid:160)
Average
(cid:160)
(cid:160)
Exercise
(cid:160)

(cid:160)
(cid:160)
Weighted-
(cid:160)
Average
(cid:160)
Remaining (cid:160)
Contractual (cid:160)
(cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)
(cid:160)
Term
(Yrs.)

(cid:160) (cid:160)

788,652

(cid:160) (cid:160)

Outstanding
December(cid:160)31,
2009

Granted

Exercised

(cid:160) (cid:160)

(cid:160) (cid:160)

Expired/Forfeited (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

Outstanding
September(cid:160)30,
2010

(cid:160)

(cid:160)

Exercisable
September(cid:160)30,
2010

1,308,600 (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

2,097,252 (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

775,819

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

$

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

$

(cid:160)

10.39 (cid:160)

6.51 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

7.97 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

10.34 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The fair value of options is estimated at the date of the grant using the Black-Scholes
option-pricing model and expensed over the options vesting periods. The following
weighted-average assumptions were used in valuing options issued during the nine months ended
September(cid:160)30, 2010. There were no options issued during 2009.

Assumptions in Estimating Option Values

EX-99.1

POWERED BY DOCRACY.COM

21

 of 

98

(cid:160)

Weighted-average volatility

Expected dividend yield

Risk-free interest rate

Expected life

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

7 years

(cid:160)

32.98

0

2.75

(cid:160)

%

%

%

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)At September(cid:160)30, 2010, unrecognized compensation cost related to nonvested stock options
of $3.2(cid:160)million is expected to be recognized over a weighted-average period of 1.85(cid:160)years. The
total fair value of shares vested during the nine months ended September(cid:160)30, 2010 was
$0.4(cid:160)million.

8

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

Note 4  Investment Securities

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The amortized cost, unrealized gains and losses and estimated fair value of securities
available-for-sale at September(cid:160)30, 2010 and December(cid:160)31, 2009 are as follows:

Amortized Cost and Fair Value of Investment Portfolio

(cid:160)
(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) Amortized (cid:160)
(cid:160)
(cid:160) Cost
(cid:160) (Dollars in
(cid:160)
thousands)

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Unrealized (cid:160)
(cid:160)
(cid:160) Gains

(cid:160)
(cid:160)
Gross (cid:160)
(cid:160)
(cid:160)

(cid:160)
(cid:160) (cid:160)
Gross (cid:160) (cid:160)

(cid:160)
(cid:160)
Unrealized (cid:160)
(cid:160)
Losses

(cid:160) Fair
(cid:160) Value

September(cid:160)30,
2010

(cid:160) (cid:160)

Securities
available-for-sale:

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

22

 of 

98

(cid:160) $

13,079 (cid:160) (cid:160)

U.S.
Government
agencies

(cid:160) (cid:160)

Residential
mortgage-backed
securities

58,778 (cid:160) (cid:160)

(cid:160) (cid:160)

25,120 (cid:160) (cid:160)

Collateralized
agency mortgage
obligations

Municipal
securities

Corporate and
other securities

(cid:160)

Total investment
securities

(cid:160)

(cid:160)

December(cid:160)31,
2009

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Securities
available-for-sale:

(cid:160) (cid:160)

$

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

$

(cid:160)

(cid:160)

(cid:160)

(cid:160)

$

(cid:160)

237

(cid:160)

640

(cid:160)

388

(cid:160)

990

(cid:160)

(cid:160)

(cid:160)

(cid:160)

2,255 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

189

(cid:160)

396

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

$ (31

(cid:160) (149

(cid:160)

(cid:160) (10

(cid:160) (137

(cid:160) (cid:160)

$ (327

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

$ (16

(cid:160) (67

13,775 (cid:160) (cid:160)

2,677

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

113,429 (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

5,586

(cid:160) (cid:160)

U.S.
Government
agencies

(cid:160) (cid:160)

Residential
mortgage-backed
securities

16,444 (cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

23

 of 

98

Collateralized
agency mortgage
obligations

Municipal
securities

Corporate and
other securities

(cid:160)

Total investment
securities

(cid:160)

(cid:160) (cid:160)

3,232

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

13,641 (cid:160) (cid:160)

3,182

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

42,085 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

$

(cid:160)

12

(cid:160)

448

(cid:160)

14

(cid:160)

(cid:160)

(cid:160)

1,059 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (23

(cid:160) (205

(cid:160) (266

(cid:160) (cid:160)

$ (577

(cid:160) (cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The amortized cost and fair values of securities available-for-sale at September(cid:160)30, 2010 and
December(cid:160)31, 2009 by contractual maturity are shown below. Expected maturities will differ from
contractual maturities because borrowers may have the right to call or prepay obligations with or
without call or prepayment penalties.

Maturities of Investment Portfolio

EX-99.1

POWERED BY DOCRACY.COM

24

 of 

98

(cid:160) (cid:160)
(cid:160) September

(cid:160)
(cid:160)

30, 2010

(cid:160) Amortized (cid:160)
(cid:160)
(cid:160) Cost
(cid:160) (Dollars in
(cid:160)
thousands)

(cid:160) (cid:160)
(cid:160) December

(cid:160) (cid:160)
(cid:160)

31, 2009

(cid:160) Fair
(cid:160) Value

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

Amortized (cid:160) (cid:160) Fair
Cost

(cid:160)
(cid:160) (cid:160) Value (cid:160)

(cid:160) $

12,551 (cid:160) (cid:160)

$ 12,692 (cid:160)

(cid:160) $ 5,055 (cid:160) (cid:160) $ 5,219 (cid:160)

(cid:160) (cid:160)

2,684

(cid:160) (cid:160)

(cid:160) 2,648

(cid:160)

(cid:160) (cid:160) 1,685 (cid:160) (cid:160) (cid:160) 1,606 (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

98,194 (cid:160) (cid:160)

(cid:160) 100,017 (cid:160)

(cid:160) (cid:160) 35,345 (cid:160) (cid:160) (cid:160) 35,742 (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

113,429 (cid:160) (cid:160)

$ 115,357 (cid:160)

(cid:160) $ 42,085 (cid:160) (cid:160) $ 42,567 (cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)

Due after
one year
through
five years

Due after
five years
through
ten years

Due after
ten years

(cid:160)

(cid:160)

Total
investment
securites

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Management periodically evaluates each investment security for other than temporary
impairment, relying primarily on industry analyst reports, observation of market conditions and
interest rate fluctuations. The following table shows gross unrealized losses and fair value,
aggregated by investment category and length of time that the individual securities have been in a
continuous unrealized loss position for investment securities with unrealized losses at September 30,
2010 and December(cid:160)31, 2009. The unrealized losses relate to municipal and debt securities that
have incurred fair value reductions due to market volatility and uncertainty since the securities were
purchased. Management believes that the unrealized losses are more likely than not to reverse as
confidence returns to

EX-99.1

POWERED BY DOCRACY.COM

25

 of 

98

9

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

investment markets. Since none of the unrealized losses relate to the marketability of the securities
or the issuers ability to honor redemption obligations, and it is more likely than not that the Bank
will not have to sell the investments before recovery of their amortized cost basis, none of the
securities are deemed to be other than temporarily impaired. Securities that have been in a loss
position for twelve months or more at September(cid:160)30, 2010 includes one municipal security and
two corporate debt securities.

Investment Portfolio Gross Unrealized Losses and Fair Value

(cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Less
Than
12
Months

(cid:160) Fair
(cid:160) Value
(cid:160) (cid:160)

September(cid:160)30,
2010

(cid:160) (cid:160)

Securities
available-for-sale:

(cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)
(cid:160) 12 Months

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)
Total (cid:160)

or More

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) Unrealized (cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Losses
(cid:160) (cid:160)
(cid:160) (cid:160)

Fair
(cid:160) (cid:160)
Value (cid:160) (cid:160)
(cid:160)

(cid:160) (Dollars in
thousands)

Unrealized (cid:160) (cid:160) Fair
Losses
(cid:160)

(cid:160) (cid:160) Value
(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) $

(cid:160) (cid:160) (cid:160)

(cid:160) $

4,969 (cid:160) (cid:160)

$ (31 )

(cid:160) $

U.S.
Government
agencies

Mortgage-backed
securities

(cid:160) (cid:160)

31,164 (cid:160) (cid:160)

(cid:160) (149 )

(cid:160) (cid:160)

Municipal
securities

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

504

(cid:160) (cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

26

 of 

98

Corporate and
other securities

(cid:160)

Total temporarily
impaired
securities

(cid:160)

(cid:160)

December(cid:160)31,
2009

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Securities
available-for-sale:

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

36,133 (cid:160) (cid:160)

$ (180 )

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

984

(cid:160) (cid:160)

$ (16 )

(cid:160) $

U.S.
Government
agencies

Mortgage-backed
securities

(cid:160) (cid:160)

5,442 (cid:160) (cid:160)

(cid:160) (67 )

(cid:160) (cid:160)

(cid:160) (cid:160)

2,555 (cid:160) (cid:160)

(cid:160) (23 )

(cid:160) (cid:160)

1,514

(cid:160) (cid:160) (cid:160)

(cid:160)

2,018

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) $

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) $

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

Collateralized
mortgage
obligations

Municipal
securities

Corporate and
other securities

(cid:160)

Total temporarily
impaired
securities

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

2,723 (cid:160) (cid:160)

(cid:160) (22 )

(cid:160) (cid:160)

3,289

(cid:160) (cid:160) (cid:160)

400

(cid:160) (cid:160)

(cid:160) (100 )

(cid:160) (cid:160)

2,016

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

12,104 (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

$ (228 )

(cid:160) (cid:160)

(cid:160) $

(cid:160)

5,305

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) $

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

27

 of 

98

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Securities with a fair value of $4.5(cid:160)million and $5.2(cid:160)million at September(cid:160)30, 2010 and
December(cid:160)31, 2009, respectively, were pledged to secure an interest rate swap and securities sold
under agreements to repurchase. During the nine months ended September(cid:160)30, 2010, the Bank
sold $2.2 million of securities available-for-sale, resulting in a gain of $0.02(cid:160)million. Securities
available-for-sale with a book value of $11.1(cid:160)million were sold in the nine months ended
September 30, 2009 resulting in a $0.3(cid:160)million gain which was offset by a $0.5(cid:160)million impairment
loss related to our investment in subordinated debt of Silverton Bank which was taken into
receivership by the FDIC.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The aggregate cost of the Banks cost method investments totaled $2.3(cid:160)million at
September(cid:160)30, 2010 and $2.4(cid:160)million at December(cid:160)31, 2009. Cost method investments at
September(cid:160)30, 2010 included $1.8(cid:160)million in Federal Home Loan Bank (FHLB) stock and
$0.5(cid:160)million of other investments which are included in other assets. All cost method investments
were evaluated for impairment as of September(cid:160)30, 2010. The following factors have been
considered in determining the carrying amount of FHLB stock: 1) managements current belief that
the Bank has sufficient liquidity to meet all operational needs in the foreseeable future and would
not need to dispose of the stock below recorded amounts, 2) managements belief that the FHLB
has the ability to absorb economic losses given the expectation that the FHLB has a high degree of
government support and 3) redemptions and purchases of the stock are at the discretion of the
FHLB. During the first nine months of 2010, the Bank estimated that the fair values of cost method
investments equaled or exceeded the cost of each of these investments, and, therefore, the
investments were not impaired. During the first nine months of 2009, the Banks investment in
common stock of

10

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

Silverton Bank was considered to be other than temporarily impaired and a $0.2(cid:160)million
impairment loss was realized.

Note 5  Loans and Allowance for Loan Losses

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following is a summary of the loan portfolio at September(cid:160)30, 2010 and December(cid:160)31,
2009:

Summary of Loans By Category

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

28

 of 

98

(cid:160) September

(cid:160)

(cid:160) Percent (cid:160) (cid:160)

December
31,
2009

(cid:160) (cid:160) Percent (cid:160)

(cid:160) (cid:160) of

(cid:160)

Loans

(cid:160) of

(cid:160) (cid:160)

Loans

30,

(cid:160) 2010

(cid:160) (Dollars in
thousands)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

Secured by
real estate:

One to four
family
residential

Commercial
real estate

Construction
and
development

Home equity
line of credit

(cid:160) (cid:160)

(cid:160)

Total real
estate loans

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Other loans: (cid:160) (cid:160)

Commercial
and industrial

(cid:160) (cid:160)

Loans to
individuals

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

43,791 (cid:160) (cid:160)

(cid:160) 11.0 %

(cid:160) $ 42,782

(cid:160) (cid:160) (cid:160) 10.8 %

133,133 (cid:160) (cid:160)

(cid:160) 33.5 %

(cid:160) (cid:160) 126,609 (cid:160) (cid:160) (cid:160) 31.8 %

109,138 (cid:160) (cid:160)

(cid:160) 27.4 %

(cid:160) (cid:160) 127,811 (cid:160) (cid:160) (cid:160) 32.1 %

58,115 (cid:160) (cid:160)

(cid:160) 14.6 %

(cid:160) (cid:160) 52,026

(cid:160) (cid:160) (cid:160) 13.1 %

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

344,177 (cid:160) (cid:160)

(cid:160) 86.6 %

(cid:160) (cid:160) 349,228 (cid:160) (cid:160) (cid:160) 87.8 %

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)

47,166 (cid:160) (cid:160)

(cid:160) 11.9 %

(cid:160) (cid:160) 41,914

(cid:160) (cid:160) (cid:160) 10.5 %

6,412

(cid:160) (cid:160)

(cid:160) 1.6 %

(cid:160) (cid:160) 6,535

(cid:160) (cid:160) (cid:160) 1.6 %

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

29

 of 

98

Total other
loans

(cid:160)

(cid:160)

Deferred fees,
net

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

53,578 (cid:160) (cid:160)

(cid:160) 13.5 %

(cid:160) (cid:160) 48,449

(cid:160) (cid:160) (cid:160) 12.2 %

(cid:160)

(cid:160)

(97

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (113

) (cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

Total loans

(cid:160) $

397,658 (cid:160) (cid:160)

(cid:160) 100.0 %

(cid:160) $ 397,564 (cid:160) (cid:160) (cid:160) 100.0 %

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Loans are primarily made in the Charlotte and Wilmington regions of North Carolina. Real
estate loans can be affected by the condition of the local real estate market. Commercial and
industrial loans can be affected by the local economic conditions.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)At September(cid:160)30, 2010, the Bank had loan commitments outstanding of $9.0(cid:160)million and
pre-approved but unused lines of credit totaling $66.5(cid:160)million. Additional commitments totaling
$2.2(cid:160)million were outstanding under performance and financial letters of credit. At December(cid:160)31,
2009, the Bank had loan commitments outstanding of $6.3(cid:160)million and undisbursed lines of credit
totaling $71.0(cid:160)million. In managements opinion, these commitments represent no more than
normal lending risk to the Bank and will be funded from normal sources of liquidity.

11

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following is an analysis of the change in allowance for loan losses for the three and nine
month periods ended September(cid:160)30, 2010 and 2009:

Changes in the Allowance for Loan Losses

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

30

 of 

98

(cid:160) Three

(cid:160)

(cid:160) Nine

(cid:160)

Months
Ended

Months
Ended

(cid:160) September

(cid:160)

(cid:160) September

(cid:160)

30,

(cid:160) 2010
(cid:160) (cid:160)

30,

(cid:160) 2009
(cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160)
(cid:160)

Beginning
balance

(cid:160) $

8,974 (cid:160) (cid:160)

Provision for
loan losses

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

Sub-total

(cid:160)

(cid:160)

Loans
charged-off:

One to four
family
residential

Commercial
real estate

(cid:160) (cid:160)

(cid:160) (cid:160)

Construction
and
development

6,143 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

15,117 (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

429

(cid:160) (cid:160)

105

(cid:160) (cid:160)

1,262 (cid:160) (cid:160)

(cid:160) (cid:160)

190

(cid:160) (cid:160)

Commercial
and
industrial(cid:160)

Loans to
individuals

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)
(Dollars in
thousands)
$

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)
(cid:160)

2010 (cid:160) (cid:160) 2009
(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

6,226 (cid:160)

(cid:160) $ 7,402 (cid:160) (cid:160) $ 5,568

1,150 (cid:160)

(cid:160) (cid:160) 8,768 (cid:160) (cid:160) (cid:160) 1,854

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

7,376 (cid:160)

(cid:160) (cid:160) 16,170 (cid:160) (cid:160) (cid:160) 7,422

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 545

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 105

(cid:160) (cid:160) (cid:160)

327

(cid:160)

(cid:160) (cid:160) 1,774 (cid:160) (cid:160) (cid:160) 327

8

(cid:160)

(cid:160)

(cid:160) (cid:160) 618

(cid:160) (cid:160) (cid:160) 8

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) 46

EX-99.1

POWERED BY DOCRACY.COM

31

 of 

98

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

Total loans
charged-off

(cid:160)

(cid:160)

Recoveries
of loans
charged-off:

One to four
family
residential

(cid:160)

(cid:160) (cid:160)

1,986 (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

2

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Commercial
real estate

(cid:160) (cid:160)

16

(cid:160) (cid:160)

Commercial
and
industrial

(cid:160)

Total
recoveries of
loans
charged-off

(cid:160)

Net loans
charged-off

(cid:160)

Ending
balance

(cid:160)

(cid:160) (cid:160)

1

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160)

19

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

1,967 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

13,150 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

$

(cid:160)

(cid:160)

335

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

335

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 3,042 (cid:160) (cid:160) (cid:160) 381

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 5

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 16

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 1

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 22

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 3,020 (cid:160) (cid:160) (cid:160) 381

(cid:160) (cid:160) (cid:160)

(cid:160)

7,041 (cid:160)

(cid:160) $ 13,150 (cid:160) (cid:160) $ 7,041

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)During the nine month period ended September(cid:160)30, 2010, the Bank had an average

EX-99.1

POWERED BY DOCRACY.COM

32

 of 

98

investment in impaired loans of $3.4(cid:160)million. The amount of interest related to these impaired
loans the Bank was unable to recognize amounted to $0.3(cid:160)million. At September(cid:160)30, 2010, there
were $22.6 of nonaccrual, restructured and impaired loans.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The Bank engages in loan transactions with its directors and executive officers. Such loans are
made in the ordinary course of business and on substantially the same terms and collateral as those
for comparable transactions prevailing at the time and do not involve more than the normal risk of
collectability or present other unfavorable features. A summary of loan transactions to directors,
executive officers and their related interests is as follows:

Loans to Directors, Executive Officers and Their Related Interests

(cid:160)
(cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Nine Months

(cid:160)
(cid:160)

Ended

(cid:160) (cid:160)
(cid:160) Year

Ended

(cid:160)

(cid:160) (cid:160)
(cid:160)

(cid:160) September 30, (cid:160)

(cid:160) December

(cid:160)

31,

(cid:160) 2009

(cid:160)

(cid:160) 2010
(cid:160) (Dollars in
thousands)

(cid:160)
(cid:160)

13,913 (cid:160) (cid:160)

$ 11,789 (cid:160)

2,146 (cid:160) (cid:160)

(cid:160) 7,872 (cid:160)

(3,251 ) (cid:160)

(cid:160) (5,748 )

(8,137 ) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

4,671 (cid:160) (cid:160)

$ 13,913 (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

Beginning balance

Disbursements

Repayments

Loans associated with former board
members and executive officers

(cid:160)

Ending balance

(cid:160)

12

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

EX-99.1

POWERED BY DOCRACY.COM

33

 of 

98

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)At September(cid:160)30, 2010 and December(cid:160)31, 2009, the Bank had pre-approved but unused
lines of credit totaling $1.4(cid:160)million and $4.6(cid:160)million, respectively, to directors, executive officers
and their related interests.

Note 6  Per Share Results

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Basic and diluted net earnings (loss)(cid:160)per common share are computed based on the
weighted-average number of shares outstanding during each period. Diluted net earnings (loss)(cid:160)per
common share reflect the potential dilution that could occur if outstanding stock options were
exercised.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Basic and diluted net earnings (loss)(cid:160)per common share have been computed based upon net
income (loss)(cid:160)as presented in the accompanying statements of income (loss)(cid:160)divided by the
weighted-average number of common shares outstanding or assumed to be outstanding as
summarized below:

Weighted-Average Shares for Earnings Per Share Calculation

EX-99.1

POWERED BY DOCRACY.COM

34

 of 

98

(cid:160)
(cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Three

Months
Ended

(cid:160) (cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Nine

Months
Ended

(cid:160) September

(cid:160)

(cid:160) September

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

30,

(cid:160) 2010
(cid:160) (cid:160)

30,

(cid:160) 2009

(cid:160)
15,998,924 (cid:160) (cid:160)

2010 (cid:160) (cid:160) 2009

(cid:160)

(cid:160) (cid:160)
(cid:160) 4,951,098 (cid:160)

(cid:160) (cid:160) 8,674,175 (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

15,998,924 (cid:160) (cid:160)

(cid:160) 4,951,098 (cid:160)

(cid:160) (cid:160) 8,674,175 (cid:160) (cid:160) (cid:160)

(cid:160)
Weighted-average
number of
common shares
outstanding

Effect of dilutive
stock options

(cid:160)

Weighted-average
number of
common shares
and dilutive
potential
common shares
outstanding

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)For the three and nine month periods ended September(cid:160)30, 2010 and 2009, 2,097,252 and
793,236 options outstanding, respectively, were anti-dilutive due to the exercise price exceeding
the average market price for the periods and were omitted from the calculation.

13

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

Note 7  Total Comprehensive Income (Loss)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The components of comprehensive income (loss)(cid:160)and related tax effects for the three and

EX-99.1

POWERED BY DOCRACY.COM

35

 of 

98

nine month periods ended September(cid:160)30, 2010 and 2009 are as follows:

Comprehensive Income (Loss)

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Three

Months
Ended

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Nine

Months
Ended

(cid:160) September

(cid:160)

(cid:160) September

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

30,

(cid:160) 2010
(cid:160) (cid:160)

30,

(cid:160) 2009
(cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Net income
(loss)(cid:160)after tax

Unrealized
holding gains on
available-for-sale
securities

Tax effect

Reclassification
of (gain)(cid:160)loss
recognized in
net income

Tax effect

(cid:160)

(cid:160)

(cid:160)

Unrealized
holding gains
(loss)(cid:160)on swaps

(3,668 ) (cid:160)

683

(cid:160) (cid:160)

(264

) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

419

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(164

) (cid:160)

Tax effect

(cid:160) (cid:160)

63

(cid:160) (cid:160)

(cid:160)
(Dollars in
thousands)
(cid:160)

(cid:160)
(cid:160)

2010 (cid:160) (cid:160) 2009 (cid:160)
(cid:160)

(cid:160) (cid:160) (cid:160)

116

(cid:160)

(cid:160) (cid:160) (3,339 ) (cid:160) (cid:160) 459

$

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

1,714 (cid:160)

(cid:160) $ 1,465 (cid:160) (cid:160) $ 573

(661 )

(cid:160) (cid:160) (565

) (cid:160) (cid:160) (222

(cid:160)

(cid:160) (cid:160) (19

) (cid:160) (cid:160) 151

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) 7

(cid:160) (cid:160) (cid:160) (58

(cid:160) (cid:160) (cid:160)

(cid:160)

1,053 (cid:160)

(cid:160) (cid:160) 888

(cid:160) (cid:160) (cid:160) 444

(cid:160)

10

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (453

) (cid:160) (cid:160) (683

(4

)

(cid:160) (cid:160) 175

(cid:160) (cid:160) (cid:160) 263

EX-99.1

POWERED BY DOCRACY.COM

36

 of 

98

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160)

(cid:160)

(cid:160)

Reclassification
of gain
recognized on
unwound swap
in net income

Tax effect

(cid:160)

(cid:160)

(cid:160)

Total
comprehensive
income (loss)

(cid:160)

(cid:160) (cid:160)

(101

) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(3,350 ) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

$

(cid:160)

(cid:160)

6

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (278

) (cid:160) (cid:160) (420

(cid:160) (cid:160) (cid:160)

(cid:160)

(130 )

(cid:160) (cid:160) (352

) (cid:160) (cid:160) (637

59

(cid:160)

(71

(cid:160)

(cid:160)

(cid:160)

)

(cid:160)

(cid:160) (cid:160) 136

(cid:160) (cid:160) (cid:160) 246

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (216

) (cid:160) (cid:160) (391

(cid:160) (cid:160) (cid:160)

(cid:160)

1,104 (cid:160)

(cid:160) $ (2,945 ) (cid:160) $ 92

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

Note 8  Derivative Financial Instruments and Hedging Activities

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The Bank entered into an interest rate swap agreement during June(cid:160)2007 with a notional
amount of $40.0(cid:160)million. The derivative instrument was used to protect certain designated variable
rate loans from the downward effects of their repricing in the event of a decreasing rate
environment for a period of three years ending June(cid:160)2010. This swap was terminated on
January(cid:160)29, 2008. The gain on the terminated swap was $2.0(cid:160)million. The amount of this gain was
recognized in interest income over the remaining term of the swap, as if it had not been
terminated, with the final amount recognized in income during June(cid:160)2010. The Bank recorded
income on the terminated swap of $0.4 million and $0.6(cid:160)million for the nine months ended
September(cid:160)30, 2010 and 2009, respectively.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)During May(cid:160)2008, the Bank entered into an interest rate swap agreement with a notional
amount of $40.0(cid:160)million. The derivative instrument is used to protect certain designated variable
rate loans from the downward effects of their repricing in the event of a decreasing rate
environment for a period of three years ending May(cid:160)16, 2011. If the USD-Prime-H. 15 rate
(Prime Rate) remains below 6.22%, the Bank receives the difference between 6.22% and the daily
weighted-average Prime Rate for each period. If the Prime Rate increases above 6.22% during the

EX-99.1

POWERED BY DOCRACY.COM

37

 of 

98

term of the contract, the Bank will pay the difference between 6.22% and the daily
weighted-average Prime Rate for each period. At September(cid:160)30, 2010, the derivative instrument is
carried at the fair market value of $0.7(cid:160)million and is included in other assets. The fair market value

EX-99.1

POWERED BY DOCRACY.COM

38

 of 

98

of this swap at December(cid:160)31, 2009 was $1.1(cid:160)million. Changes in fair value of the hedge that are
deemed effective are recorded in other comprehensive income net of tax. Changes in fair value for
the ineffective portion of the hedge are recorded in interest income; such amounts were

14

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

insignificant for the nine months ended September(cid:160)30, 2010 and 2009, respectively. The Bank
recorded interest income on the swap of $0.9(cid:160)million for the nine months ended September(cid:160)30,
2010 and 2009, respectively.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)During the year ended December(cid:160)31, 2008, the Bank entered into five loan swaps. The total
original notional amount of these loan swaps was $11.2(cid:160)million. These derivative instruments are
used to protect the Bank from interest rate risk caused by changes in the LIBOR curve in relation
to certain designated fixed rate loans. The derivative instruments are used to convert these fixed
rate loans to an effective floating rate. If the LIBOR rate is below the stated fixed rate of the loan
for a given period, the Bank will owe the floating rate payer the notional amount times the
difference between LIBOR and the stated fixed rate. If LIBOR is above the stated rate for any
given period during the term of the contract, the Bank will receive payments based on the notional
amount times the difference between LIBOR and the stated fixed rate. These derivative
instruments are carried at a fair market value of $(0.7) million and $(0.5) million and are included in
loans at September(cid:160)30, 2010 and December(cid:160)31, 2009, respectively. Changes in fair value of the
hedged loans have been completely offset by the fair value changes in the derivatives. The Bank
recorded interest expense on these loan swaps of $0.3(cid:160)million in the nine months ended
September(cid:160)30, 2010 and 2009.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)See table below for the information on the individual loan swaps at September(cid:160)30, 2010:

Individual Loan Swap Information
(Dollars in thousands)

EX-99.1

POWERED BY DOCRACY.COM

39

 of 

98

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Current (cid:160) (cid:160)
(cid:160) Notional (cid:160) (cid:160)
(cid:160) Amount (cid:160) (cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)
Original (cid:160)
Notional (cid:160)
Amount (cid:160)
$
(cid:160)
(cid:160)
(cid:160)
(cid:160)
(cid:160)
$
(cid:160)
Note 9- Fair Value Measurements

2,670 (cid:160) (cid:160)
1,800 (cid:160) (cid:160)
1,100 (cid:160) (cid:160)
3,775 (cid:160) (cid:160)
1,870 (cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160)
11,215 (cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)
(cid:160) (cid:160) (cid:160)
(cid:160) (cid:160) (cid:160)

(cid:160)
(cid:160)
(cid:160)
Termination (cid:160) (cid:160) Fixed
(cid:160) (cid:160) Rate
Date
(cid:160)
$ 997
04/10/13 (cid:160) (cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160) 04/09/13 (cid:160) (cid:160) (cid:160)
(cid:160) 1,691 (cid:160)
(cid:160) (cid:160) 05/11/13 (cid:160) (cid:160) (cid:160)
(cid:160) 1,034 (cid:160)
(cid:160) (cid:160) 02/15/13 (cid:160) (cid:160) (cid:160)
(cid:160) 3,610 (cid:160)
(cid:160) 1,676 (cid:160)
(cid:160) (cid:160) 02/15/13 (cid:160) (cid:160) (cid:160)
(cid:160) (cid:160) (cid:160)
(cid:160) (cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160) (cid:160)
(cid:160) (cid:160) (cid:160)
$ 9,008 (cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160) (cid:160)
(cid:160) (cid:160) (cid:160)

(cid:160)
(cid:160) (cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160) (cid:160)
(cid:160) (cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160) Floating (cid:160)
(cid:160)
(cid:160) (cid:160) Rate
5.85 % (cid:160)
5.80 % (cid:160)
6.04 % (cid:160)
5.90 % (cid:160)
5.85 % (cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160)
(cid:160) (cid:160)

(cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160)
(cid:160) Payer (cid:160)
(cid:160) Spread (cid:160)

USD-LIBOR-BBA
USD-LIBOR-BBA
USD-LIBOR-BBA
USD-LIBOR-BBA
USD-LIBOR-BBA
(cid:160)
(cid:160)
(cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The Bank is required to disclose the estimated fair value of financial instruments, both assets
and liabilities on and off the balance sheet, for which it is practicable to estimate fair value. These
fair value estimates are made at each balance sheet date, based on relevant market information and
information about the financial instruments. Fair value estimates are intended to represent the price
an asset could be sold at or the price a liability could be settled for in an orderly transaction
between market participants at the measurement date. However, given there is no active market or
observable market transactions for many of the Banks financial instruments, the Bank has made
estimates of many of these fair values which are subjective in nature, involve uncertainties and
matters of significant judgment and therefore cannot be determined with precision. Changes in
assumptions could significantly affect the estimated values. The methodologies used for estimating
the fair value of financial assets and financial liabilities are discussed below:

Cash and Cash Equivalents

The carrying amounts of cash and short-term instruments including due from banks and federal
funds sold approximate their fair value.

15

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

EX-99.1

POWERED BY DOCRACY.COM

40

 of 

98

Investment Securities

Fair value for investment securities is based on the quoted market price if such information is
available. If a quoted market price is not available, fair values are based on quoted market prices of
comparable instruments.

FHLB Stock

The Bank, as a member of the FHLB, is required to maintain an investment in FHLB capital stock
and the carrying amount is estimated to be fair value.

Loans

For certain homogenous categories of loans, such as residential mortgages, fair value is estimated
using the quoted market prices for securities backed by similar loans, adjusted for differences in loan
characteristics. The fair value of other types of loans is estimated by discounting the future cash
flows using the current rates at which similar loans would be made to borrowers with similar credit
ratings and for the same remaining maturities. Further adjustments are made to reflect current
market conditions. There is no discount for liquidity included in the expected cash flow
assumptions.

Accrued Interest Receivable

The carrying amount is a reasonable estimate of fair value.

Deposits

The fair value of deposits that have no stated maturities, including demand deposits, savings, money
market and NOW accounts, is the amount payable on demand at the reporting date. The fair value
of deposits that have stated maturity dates, primarily time deposits, is estimated by discounting
expected cash flows using the rates currently offered for instruments of similar remaining maturities.

Borrowings

The fair values of short-term and long-term borrowings are based on discounting expected cash
flows at the interest rate for debt with the same or similar remaining maturities and collateral
requirements.

Accrued Interest Payable

The carrying amount is a reasonable estimate of fair value.

Financial Instruments with Off-Balance Sheet Risk

With regard to financial instruments with off-balance sheet risk discussed in Note K of our audited
financial statements included in the Registration Statement, it is not practicable to estimate the fair
value of future financing commitments.

EX-99.1

POWERED BY DOCRACY.COM

41

 of 

98

Derivative Instruments

Derivative instruments, including interest rate and loan swaps, are recorded at fair value on a
recurring basis. Fair value measurement is based on discounted cash flow models. All future floating
cash flows are projected and both floating and fixed cash flows are discounted to the valuation date.

16

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The carrying amounts and estimated fair values of the Banks financial instruments, none of
which are held for trading purposes, at September(cid:160)30, 2010 and December(cid:160)31, 2009 are as
follows:

Financial Instruments Carrying Amounts and Estimated Fair Values

(cid:160) (cid:160)
(cid:160) September

(cid:160)
(cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)

30, 2010
(cid:160) Carrying
(cid:160) Amount

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160)
(cid:160)

(cid:160)
(cid:160)

(cid:160)

Financial
assets:

Cash and
due from
banks

Federal
funds sold

(cid:160) (cid:160)

Investment
securities

(cid:160) (cid:160)

(cid:160)

17,450 (cid:160)

96,560 (cid:160)

115,357 (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)
December
31, 2009
Estimated (cid:160) Carrying
Fair
(cid:160) Amount
Value
(cid:160)

(cid:160) (Dollars in
thousands)

(cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

Estimated
Fair
Value
(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

17,450 (cid:160)

(cid:160) $ 9,262

(cid:160)

(cid:160)

96,560 (cid:160)

(cid:160) (cid:160) 13,975 (cid:160)

115,357 (cid:160)

(cid:160) (cid:160) 42,567 (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

42

 of 

98

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

1,825

(cid:160)

384,508 (cid:160)

696

1,732

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

103,107 (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

1,825

(cid:160)

(cid:160) (cid:160) 1,896

(cid:160)

379,518 (cid:160)

(cid:160) (cid:160) 390,162 (cid:160)

696

1,732

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) 1,149

(cid:160) (cid:160) 1,614

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

103,107 (cid:160)

(cid:160) $ 76,393 (cid:160)

(cid:160) (cid:160)

314,042 (cid:160)

(cid:160) (cid:160)

314,118 (cid:160)

(cid:160) (cid:160) 316,240 (cid:160)

FHLB
stock

Loans, net
of
allowance

Interest
rate swap

Accrued
interest
receivable

(cid:160)

Financial
liabilities:

Deposits
with no
stated
maturity

Deposits
with stated
maturities

Borrowings (cid:160) (cid:160)

(cid:160) (cid:160)

Accrued
interest
payable

27,995 (cid:160)

282

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

26,960 (cid:160)

(cid:160) (cid:160) 33,884 (cid:160)

282

(cid:160)

(cid:160) (cid:160) 436

(cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The Bank utilizes fair value measurements to record fair value adjustments to certain assets
and liabilities and to determine fair value disclosures. Securities available-for-sale are recorded at fair
value on a recurring basis. Additionally, from time to time, the Bank may be required to record at
fair value other assets on a nonrecurring basis. These nonrecurring fair value adjustments typically
involve application of lower of cost or market accounting or write-downs of individual assets.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The Bank groups assets and liabilities at fair value in three levels, based on the markets in
which the assets and liabilities are traded and the reliability of the assumptions used to determine
fair value.

EX-99.1

POWERED BY DOCRACY.COM

43

 of 

98

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) Level

(cid:160) Valuation is based upon quoted prices for identical instruments traded in active

1
(cid:160) (cid:160) (cid:160)

markets.

(cid:160) (cid:160)

(cid:160) (cid:160) Level

(cid:160) Valuation is based upon quoted prices for similar instruments in active markets,

2

quoted prices for identical or similar instruments in markets that are not active and
model-based valuation techniques for which all significant assumptions are observable
in the market.

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) Level

(cid:160) Valuation is generated from model-based techniques that use at least one significant

3

assumption not observable in the market. These unobservable assumptions reflect
estimates of assumptions that market participants would use in pricing the asset or
liability. Valuation techniques may include the use of option pricing models,
discounted cash flow models and similar techniques.

Following is a description of valuation methodologies used for assets and liabilities recorded at fair
value:

Investment Securities Available-for-Sale

Investment securities available-for-sale are recorded at fair value on a recurring basis. Fair value
measurement is based upon quoted prices, if available. If quoted prices are not available, fair values
are measured using independent pricing models or other model-based valuation techniques such as
present value of future cash flows, adjusted for the securitys credit rating, prepayment assumptions
and other factors such as credit loss assumptions. Level 1 securities include those traded on an active
exchange,

17

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

such as the New York Stock Exchange, U.S. Treasury securities that are traded by dealers or
brokers in active over-the-counter markets and money market funds. Level 2 securities include
mortgage-backed securities issued by government-sponsored entities, municipal bonds and
corporate debt securities that are valued using quoted prices for similar instruments in active
markets. Securities classified as Level 3 include a corporate debt security in a less liquid market
whose value is determined by reference to the going rate of a similar debt security if it were to

EX-99.1

POWERED BY DOCRACY.COM

44

 of 

98

enter the market at period end. The derived market value requires significant management
judgment and is further substantiated by discounted cash flow methodologies.

Derivative Instruments

Derivative instruments held or issued by the Bank for risk management purposes are traded in
over-the-counter markets where quoted market prices are not readily available. For those
derivatives, the Bank uses a third party to measure the fair value. The Bank classifies derivatives
instruments held or issued for risk management purposes as Level 2. As of September(cid:160)30, 2010, the
Banks derivative instruments consist of interest rate and loan swaps.

Loans

Loans for which it is probable that payment of interest and principal will not be made in
accordance with the contractual terms of the loan agreement are considered impaired. Once a loan
is identified as individually impaired, management measures it for the estimated impairment. The
fair value of impaired loans is estimated using one of several methods, including collateral value, a
loans observable market price and discounted cash flows. Those impaired loans not requiring a
specific allowance represent loans for which the fair value exceeds the recorded investments in such
loans. Impaired loans where a specific allowance is established based on the fair value of collateral
require classification in the fair value hierarchy. When the fair value of the collateral is based on an
observable market price or a current appraised value, the Bank records the impaired loan as
nonrecurring Level 2. When an appraised value is not available or management determines the fair
value of the collateral is further impaired below the appraised value and there is no observable
market price for the collateral, the Bank records the impaired loan as nonrecurring Level 3.

At September(cid:160)30, 2010 and December(cid:160)31, 2009, substantially all of the total impaired loans were
evaluated based on the fair value of the collateral. The Bank recorded the five loans involved in
loan swaps at fair market value on a recurring basis. The Bank does not record other loans at fair
value on a recurring basis.

Other real estate owned

Other real estate owned (OREO) is adjusted to fair value upon transfer of the loans to OREO.
Subsequently, OREO is carried at the lower of carrying value or fair value. Fair value is based
upon independent market prices, appraised values of the collateral or managements estimation of
the value of the collateral. When the fair value of the collateral is based on an observable market
price or a current appraised value, the Bank records the foreclosed asset as nonrecurring Level 2.
When an appraised value is not available or management determines the fair value of the collateral
is further impaired below the appraised value and there is not an observable market price for the
collateral, the Bank records the OREO as nonrecurring Level 3.

18

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

45

 of 

98

PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

Assets and Liabilities Recorded at Fair Value on a Recurring Basis

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The table below presents, by level, the recorded amount of assets and liabilities at September
30, 2010 and December(cid:160)31, 2009 measured at fair value on a recurring basis:

Fair Value on a Recurring Basis

(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)
(cid:160) Quoted

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Significant (cid:160) (cid:160)

Prices
in

(cid:160) Active

(cid:160) Other

(cid:160) Significant

(cid:160)
(cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160)

Markets
for

(cid:160) Identical

(cid:160) Observable

(cid:160) Unobservable

(cid:160)

Assets/Liabilities

Description

(cid:160)

Assets
(cid:160) (Level

1)
(cid:160) (cid:160)

September(cid:160)30,
2010

(cid:160) (cid:160)

(cid:160) $

U.S.
Government
agencies

Mortgage-backed
securities

(cid:160) (cid:160)

Collateralized
mortgage
obligations

Municipal
securities

(cid:160) (cid:160)

(cid:160) (cid:160)

Inputs

Inputs

(cid:160) (Level 2)

(cid:160) (Level 3)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (Dollars in
thousands)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

at Fair Value

(cid:160)

(cid:160)

13,285 (cid:160)

59,269 (cid:160)

25,508 (cid:160)

14,755 (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

46

 of 

98

Debt Securities

(cid:160) (cid:160)

Other Securities (cid:160) (cid:160)

Interest rate swap (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160)

December(cid:160)31,
2009

U.S.
Government
agencies

Mortgage-backed
securities

(cid:160) (cid:160)

Collateralized
mortgage
obligations

Municipal
securities

(cid:160) (cid:160)

(cid:160) (cid:160)

Debt Securities

(cid:160) (cid:160)

Other Securities (cid:160) (cid:160)

Interest rate swap (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

2,145 (cid:160)

696

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

5,759 (cid:160)

16,773 (cid:160)

3,221 (cid:160)

13,884 (cid:160)

(cid:160)

2,530 (cid:160)

1,149 (cid:160)

(cid:160) (cid:160) 395

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) 400

(cid:160) (cid:160)

(cid:160) (cid:160)

There were no transfers between Level 1 and Level 2 during the nine months ended
September(cid:160)30, 2010.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following are reconciliations of the beginning and ending balances for assets measured at
fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine
months ended September(cid:160)30, 2010 and 2009:

Level 3 Assets Reconciliation
(Dollars in thousands)

EX-99.1

POWERED BY DOCRACY.COM

47

 of 

98

(cid:160)
(cid:160)
(cid:160)
Beginning balance at December(cid:160)31, 2009

Unrealized losses

(cid:160)

Ending balance at September(cid:160)30, 2010

(cid:160)

(cid:160)

Beginning balance at December(cid:160)31, 2008

Unrealized losses

Impairment writedown

(cid:160)

Ending balance at September(cid:160)30, 2009

(cid:160)

19

(cid:160) (cid:160)
(cid:160) Debt
(cid:160) Securities
(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160)

(cid:160)

)

(cid:160)

(cid:160)

(cid:160)

)

)

(cid:160)

(cid:160)
(cid:160)
(cid:160)
400

(5

(cid:160)

395

(cid:160)

(cid:160)

1,000

(100

(500

(cid:160)

400

(cid:160)

(cid:160)
PARK STERLING BANK
Notes to Condensed Financial Statements, continued
(Unaudited)

Assets Recorded at Fair Value on a Nonrecurring Basis

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Assets measured at fair value on a nonrecurring basis at September(cid:160)30, 2010 and
December(cid:160)31, 2009 are included in the table below by level:

Fair Value on a Nonrecurring Basis

EX-99.1

POWERED BY DOCRACY.COM

48

 of 

98

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Quoted

Prices

(cid:160) in Active
(cid:160) Markets

for

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160) Significant (cid:160) (cid:160)
(cid:160) Other

(cid:160) Significant

(cid:160)
(cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)
Description (cid:160) (Level 1)

(cid:160) Identical
(cid:160) Assets

(cid:160) Observable (cid:160) Unobservable (cid:160)
(cid:160) Inputs
(cid:160)
(cid:160)
(cid:160) (Level 2)

(cid:160) Inputs
(cid:160) (Level 3)

Assets/
(Liabilities)
at Fair
Value

(cid:160)

(cid:160) (Dollars in
thousands)

September(cid:160)30,
2010

(cid:160) (cid:160)

Other real
estate owned

(cid:160) $

Impaired loans (cid:160) $

(cid:160)

December(cid:160)31,
2009

Other real
estate owned

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

Impaired loans (cid:160) $

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) $

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

1,441 (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) $ 14,755 (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

1,550 (cid:160)

(cid:160) $

(cid:160)

(cid:160) $ 5,328 (cid:160) (cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In accordance with accounting for foreclosed property, the carrying value of other real estate
owned is periodically reviewed and written down to fair value and any loss is included in earnings.
No write-downs occurred in the nine months ended September(cid:160)30, 2010 and 2009.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)There were no transfers between valuation levels for any accounts for the quarter ended
September(cid:160)30, 2010. If different valuation techniques are deemed necessary, we would consider
those transfers to occur at the end of the period that the accounts are valued.

Note 10  Commitments and Contingencies

EX-99.1

POWERED BY DOCRACY.COM

49

 of 

98

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In the normal course of business, there are various outstanding commitments and contingent
liabilities, such as commitments to extend credit, which are not reflected in the accompanying
condensed financial statements. See Note 6 for a description and amounts of outstanding
commitments as of September(cid:160)30, 2010 and December(cid:160)31, 2009.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)As of September(cid:160)30, 2010 and December(cid:160)31, 2009, the Bank has a commitment to fund
$0.6(cid:160)million related to an agreement with the Small Business Investment Corporation.

Note 11  Subsequent Events

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)On October(cid:160)22, 2010, the board of directors approved a reorganization plan, subject to
stockholder and regulatory approval, whereby the Bank would become a wholly owned subsidiary
of Park Sterling Corporation, a newly formed holding company. This plan is intended to facilitate
execution of the acquisition component of the Banks growth plans. On November(cid:160)23, 2010, at a
special meeting of stockholders of the Bank, stockholders will vote on this plan. Additionally,
stockholders will vote with respect to the approval of the Park Sterling Bank 2010 Stock Option
Plan for Directors and the Park Sterling Bank 2010 Employee Stock Option Plan, which were
approved by the board of directors on July(cid:160)20, 2010, as well as the Park Sterling Corporation 2010
Long-Term Incentive Plan, which will be adopted by the board of directors of Park Sterling
Corporation.

20

(cid:160)
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)This report contains, and Park Sterling Bank (the Bank) and its management may make,
certain statements that constitute forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements can be identified by the fact that they
do not relate strictly to historical or current facts and often use words such as may, plan,
contemplate, anticipate, believe, intend, continue, expect, project, predict, estimate, could, should,
would, will, goal, target and similar expressions. The forward-looking statements made represent
the Banks current expectations, plans or forecasts of its future results and condition, including
expectations regarding its new business strategy of engaging in bank mergers and organic growth
and anticipated asset size, investment of proceeds of its common stock offering, refinement of the
loan loss allowance methodology, recruiting of key leadership positions, decreases in construction
and development loans, increases in deposit accounts, capital levels, net interest income, credit
trends and conditions, including loan losses, allowance, charge-offs, delinquency trends and
nonperforming asset levels, and other similar matters. These statements are not guarantees of future
results or performance and involve certain risks and uncertainties that are based on our beliefs and
assumptions and on the information available to us at the time that these disclosures were prepared.
Actual outcomes and results may differ materially from those expressed in, or implied by, any of
these forward-looking statements.

EX-99.1

POWERED BY DOCRACY.COM

50

 of 

98

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)You should not place undue reliance on any forward-looking statement and should consider
all of the following uncertainties and risks, as well as those more fully discussed in any of the Banks
filings with the FDIC; the Banks inability to identify and successfully negotiate and complete
combinations with potential merger partners or to successfully integrate such businesses into the
Bank, including the Banks ability to realize the benefits and cost savings from and limit any
unexpected liabilities acquired as a result of any such business combination; the effects of negative
economic conditions, including stress in the commercial real estate markets or delay or failure of
recovery in the residential real estate markets; changes in consumer and investor confidence and the
related impact on financial markets and institutions; changes in interest rates; failure of assumptions
underlying the establishment of our allowance; deterioration in the credit quality of our loan
portfolios or in the value of the collateral securing those loans; deterioration in the value of
securities held in our investment securities portfolio; legal and regulatory developments; increased
competition from both banks and nonbanks; changes in accounting standards, rules and
interpretations, inaccurate estimates or assumptions in accounting and the impact on the Banks
financial statements; the Banks ability to attract new employees; and managements ability to
effectively manage credit risk, market risk, operational risk, legal risk, and regulatory and
compliance risk.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Forward-looking statements speak only as of the date they are made, and the Bank
undertakes no obligation to update any forward-looking statement to reflect the impact of
circumstances or events that arise after the date the forward-looking statement was made.

21

(cid:160)

Item(cid:160)2. Managements Discussion and Analysis of Financial Condition and Results of
Operations
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The purpose of this discussion and analysis is to focus on significant changes in our financial
condition and results of operations during the three and nine month periods ended September(cid:160)30,
2010. This discussion and analysis highlights and supplements information contained elsewhere in
this Quarterly Report on Form 10-Q, particularly the preceding unaudited condensed financial
statements and notes.

Overview

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Park Sterling Bank is a North Carolina-chartered commercial bank headquartered in
Charlotte, North Carolina. We conduct our existing business through three offices located in
Charlotte and Wilmington, North Carolina. Our current primary market area consists of these two
cities and surrounding areas. We commenced operations in October(cid:160)2006, with our initial branch
located in the Midtown area of Charlotte. In October(cid:160)2007, we opened a branch in Wilmington,
and in July(cid:160)2008, we opened a branch in the SouthPark neighborhood of Charlotte.

EX-99.1

POWERED BY DOCRACY.COM

51

 of 

98

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Our objective since inception has been to provide the strength and product diversity of a
larger bank and the service and relationship attention that characterizes a community bank. We
strive to develop a personal relationship with our clients while at the same time offering traditional
deposit and loan banking services. We focus on providing these personal banking services to
mid-sized businesses, real estate development and construction firms, business owners, executives,
professionals, retail clients, and others doing business or residing within our target market areas.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In August(cid:160)2010, the Bank raised gross proceeds of $150.2(cid:160)million through a public offering
of common stock to facilitate a change in the Banks business plan from primarily organic growth at
a moderate pace over the next few years to seeking to acquire regional and community banks in
the Carolinas and Virginia. We intend to become a regional-sized multi-state banking franchise
through acquisitions and organic growth, seeking to reach a consolidated asset size of between
$8(cid:160)billion and $10(cid:160)billion over the next several years. We believe the proposed size and scope will
afford the necessary scale to provide geographic and product line diversity, greater community
leadership for local markets, enhanced returns for investors and more development opportunities
for employees.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)As part of the change in strategy outlined above, the Bank reduced the size of the board and
added directors and management team members. The Banks new management team includes James
C. Cherry, who became the Chief Executive Officer; David L. Gaines, who became the Chief
Financial Officer; Leonard R. Robinett, Jr., who became Head of Corporate Development; Bryan
F. Kennedy, III, who was the President and Chief Executive Officer and remains the President;
Stephen A. Arnall, who was the Chief Financial Officer and became the Treasurer; and Frank W.
Ix, who continues to serve as the Chief Credit Officer. The board of directors now includes Leslie
M. Bud Baker, Jr., Chairman; Walter C. Ayers; Larry W. Carroll; James C. Cherry; Thomas B.
Henson; and Jeffrey S. Kane.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Our primary market area consists of the Charlotte and Wilmington, North Carolina
metropolitan statistical areas (MSAs). The Charlotte-Gastonia-Concord MSA consists of five
counties in North Carolina (Anson, Cabarrus, Gaston, Mecklenburg and Union) and one county in
South Carolina (York). The Wilmington MSA consists of New Hanover, Brunswick, and Pender
counties in Southeast North Carolina.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Commercial banking in the Charlotte and Wilmington markets and in North Carolina
generally is extremely competitive. We compete for deposits in our banking markets with other
commercial banks, savings banks and other thrift institutions, credit unions, brokerage firms and all
other organizations and institutions engaged in money market transactions. In our lending activities,
the Bank competes with all other financial institutions, as well as consumer finance companies,
mortgage companies and other lenders engaged in the business of extending credit.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Interest rates, both on loans and deposits, and prices of fee-based services, are significant
competitive factors among financial institutions. Other important competitive factors include office
location, office hours, the

EX-99.1

POWERED BY DOCRACY.COM

52

 of 

98

22

(cid:160)
quality of customer service, community reputation, continuity of personnel and services, and in the
case of larger commercial customers, relative lending limits and the ability to offer sophisticated
cash management and other commercial banking services. Many of our competitors have greater
resources, broader geographic markets and higher lending limits. To counter these competitive
disadvantages, we depend on our reputation as a community bank in our local markets, our direct
customer contact, our ability to make credit and other business decisions locally, and personalized
customer service.

Recent Accounting Pronouncements

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)See Note 2 to the unaudited condensed financial statements included in this Quarterly
Report on Form 10-Q for a description of recent accounting pronouncements including the
respective expected dates of adoption and effects on results of operations and financial condition.

Critical Accounting Policies and Estimates

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In the preparation of our financial statements, we have adopted various accounting policies
that govern the application of accounting principles generally accepted in the United States and in
accordance with general practices within the banking industry. Our significant accounting policies
are described in the notes to the audited financial statements for the year ended December(cid:160)31,
2009 filed as part of the Banks Registration Statement on Form(cid:160)10 (the Registration Statement).

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Certain accounting policies involve significant judgment and assumptions by us that have a
material impact on the carrying value of certain assets and liabilities. We consider these accounting
policies to be critical accounting policies. The judgment and assumptions we use are based on
historical experience and other factors, which we believe to be reasonable under the circumstances.
Because of the nature of the judgment and assumptions we make, actual results could differ from
these judgments and assumptions that could have a material impact on the carrying values of our
assets and liabilities and our results of operations.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)We believe our critical accounting policies and estimates include the allowance for loan losses
and the fair value of financial instruments and other accounts. Based on managements calculation,
an allowance of $13.2(cid:160)million, or 3.31% of total loans, net of unearned interest, was an adequate
estimate of potential losses within the loan portfolio at September(cid:160)30, 2010. If the mix and amount
of future charge-off percentages differ significantly from those assumptions used by management in
making its determination, the allowance for loan losses and provision for loan losses on the income
statement could be materially affected.

Financial Condition at September(cid:160)30, 2010 and December(cid:160)31, 2009

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Total assets grew by $158.8(cid:160)million or 33.5% from $473.8(cid:160)million at December(cid:160)31, 2009 to

EX-99.1

POWERED BY DOCRACY.COM

53

 of 

98

$632.6(cid:160)million at September(cid:160)30, 2010. At September(cid:160)30, 2010, interest-earning assets were
$617.8 million, which included $397.7 million in gross loans, $115.4(cid:160)million in investment
securities available-for-sale, $102.4(cid:160)million in overnight and interest-bearing deposits in other
banks and $2.3(cid:160)million in other interest-earning assets. Interest-earning assets at December(cid:160)31,
2009 totaled $459.3(cid:160)million and consisted of $397.6(cid:160)million in gross loans, $42.6(cid:160)million in
investment securities available-for-sale, $16.7(cid:160)million in overnight investments and interest-bearing
deposits in other banks and $2.4(cid:160)million in other interest-earning assets.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Stockholders equity equaled $183.8(cid:160)million at September(cid:160)30, 2010 compared to
$46.1(cid:160)million at December(cid:160)31, 2009. This increase of $137.7(cid:160)million resulted primarily from a
$140.2(cid:160)million, net of issuance costs, common stock offering completed in August(cid:160)2010. We also
recorded $0.5(cid:160)million of additional paid in capital relating to the vesting of stock options and a
$0.4(cid:160)million increase, net of taxes, in accumulated other comprehensive income relating to
unrealized gains on investments available-for-sale and swaps. These increases were offset by a net
loss of $3.3(cid:160)million for the nine months ended September(cid:160)30, 2010.

23

(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following table reflects selected ratios for the Bank for the three and nine months ended
September(cid:160)30, 2010 and 2009:

Selected Ratios

EX-99.1

POWERED BY DOCRACY.COM

54

 of 

98

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Three

months
ended

(cid:160) September

(cid:160)

30,

(cid:160) (annualized

(cid:160)

and
unaudited)

(cid:160)
Nine
months
ended
September
30,
At
December
31,
2009

(cid:160) 2010
(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)
Return
on
Average
Assets

(cid:160)

Return
on
Average
Equity

(cid:160)

Period
End
Equity
to Total
Assets

Loans

(cid:160)
-2.64 %

(cid:160) 2010 (cid:160)
(cid:160) (cid:160)

2009 (cid:160) 2009

0.10 %

(cid:160) (cid:160)

-0.88 % (cid:160) (cid:160) 0.13 % (cid:160) (cid:160) 0.13

(cid:160)

(cid:160)

-12.80 %

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

1.01 %

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

-6.39 % (cid:160) (cid:160) 1.34 % (cid:160) (cid:160) 1.26

(cid:160)

(cid:160)

29.06 %

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

9.51 %

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

29.06 % (cid:160) (cid:160) 9.51 % (cid:160) (cid:160) 9.73

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)At September(cid:160)30, 2010, total loans were $397.7(cid:160)million compared to $397.6(cid:160)million at
December 31, 2009. Although loans stayed relatively flat, we had increases in owner-occupied and
other commercial real estate, home equity lines of credit (HELOC) and commercial and industrial
loans. These increases were offset by a decrease in the construction and development portfolio of
$18.7 million, consistent with our intention to continue reducing this component of our portfolio.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Substantially all of our loans are to customers in our immediate markets. In the Charlotte
market, we have a diversified mix of commercial real estate, owner-occupied commercial real

EX-99.1

POWERED BY DOCRACY.COM

55

 of 

98

estate, commercial and small business loans, and a significant portfolio of HELOCs. Our
Wilmington operation has a heavier concentration of real estate related loans with a smaller
proportion of construction and development loans than Charlotte. Wilmington, like most coastal
markets, is heavily dependent on real estate and tourism to drive its economy. We believe we are
not dependent on any single customer or group of customers whose insolvency would have a
material adverse effect on our financial condition or results of operations.

Asset Quality and Allowance for Loan Losses

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Due to unprecedented asset quality challenges and the global economic recession, the U.S.
banking industry has been experiencing serious financial challenges. Our senior management works
closely with credit administration, third-party credit review specialists, and lending staff to ensure
that adequate resources are in place to proactively manage through the current slowdown in the
real estate market and overall economy. When a problem is identified, management is committed
to assessing the situation and moving quickly to minimize losses, while being sensitive to the
borrowers effectiveness as an operator, the long-term viability of the business or project and the
borrowers commitment to working with the Bank to achieve an acceptable resolution of the credit.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)We consider asset quality to be of primary importance, and employ a formal internal loan
review process to ensure adherence to the lending policy as approved by our board of directors. It
is the responsibility of each loan officer to assign an appropriate risk grade to loans when originated.
Our credit administration function, through the loan review process with assistance from third
party credit review specialists, validates the accuracy of the initial risk grade assessment. In addition,
as a given loans credit quality changes, it is the responsibility of our credit administration
department to change the borrowers risk grade accordingly. The process of determining the
allowance for loan losses is fundamentally driven by the risk grade system. In determining the
allowance for loan losses and any resulting provision to be charged against earnings, particular
emphasis is placed on the results of the loan review process. Consideration is also given to historical
loan loss experience, the value and adequacy of collateral, economic conditions in our market areas
and other factors. During the third quarter of 2010, the Bank introduced refinements to its loan loss
allowance methodology. The principal change is the addition of a more comprehensive qualitative
component which evaluates six environmental factors, including portfolio trends,

24

(cid:160)
portfolio concentrations, general economic and market trends, changes in lending practices,
regulatory environment and other factors. These refinements are intended to help management
recognize expected losses that may not be identified through the quantitative analysis of our
historical loss experience. For loans determined to be impaired, the allowance is based on
discounted cash flows using the loans initial effective interest rate or the fair value of the collateral
for certain collateral dependent loans. This evaluation is inherently subjective, as it requires material
estimates, including the amounts and timing of future cash flows expected to be received on

EX-99.1

POWERED BY DOCRACY.COM

56

 of 

98

impaired loans that may be susceptible to significant change. The allowance for loan losses
represents managements estimate of the appropriate level of reserve to provide for the risk inherent
in our loan portfolio.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Our policy regarding past due loans normally requires a prompt charge-off to the allowance
for loan losses following timely collection efforts and a thorough review. Further efforts are then
pursued through various means available. Loans carried in a nonaccrual status are generally secured
by collateral, which is considered in the determination of the allowance for loan losses.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following table presents selected coverage ratios:

Selected Coverage Ratios

EX-99.1

POWERED BY DOCRACY.COM

57

 of 

98

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Three

Months
Ended

(cid:160) September

(cid:160)

30,

(cid:160) 2010
(cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)
Nine
Months
Ended
September
30,
2009
(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)
(cid:160) Year

Ended

(cid:160) December

31,

(cid:160) 2010
(cid:160) (Dollars in
thousands)

(cid:160)
(cid:160)

2009 (cid:160) 2009
(cid:160)

(cid:160) (cid:160)

(cid:160) $

11,484 (cid:160)

(cid:160) $

1,273 (cid:160)

(cid:160) $

11,484 (cid:160) (cid:160)

(cid:160) (cid:160)

2.88 %

(cid:160) (cid:160)

0.32 %

(cid:160) (cid:160)

2.88 % (cid:160)

(cid:160) (cid:160)

1.97 %

(cid:160) (cid:160)

0.34 %

(cid:160) (cid:160)

1.01 % (cid:160)

(cid:160) (cid:160)

3.31 %

(cid:160) (cid:160)

1.79 %

(cid:160) (cid:160)

3.31 % (cid:160)

(cid:160) (cid:160)

114.51 %

(cid:160) (cid:160)

553.10 %

(cid:160) (cid:160)

114.51 % (cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)
(cid:160)

Nonperforming
assets
(including
OREO) $

Nonperforming
assets/total
loans + OREO
%

Annualized net
charge-offs to
total loans

Allowance for
loan losses to
total loans

Allowance for
loan losses to
nonperforming
assets

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The allowance for loan losses as a percentage of total loans increased to 3.31% at
September(cid:160)30, 2010 from 1.79% at September(cid:160)30, 2009. At December(cid:160)31, 2009, the allowance
for loan losses as a percentage of total loans was 1.86%. The increase is related to a refinement in
allowance methodology to incorporate a more comprehensive qualitative component, the effects of
extended economic weakness on portfolio trends, and specific reserves related to impaired loans.

EX-99.1

POWERED BY DOCRACY.COM

58

 of 

98

We had net charge-offs of $3.0(cid:160)million in the first nine months of 2010 compared to $0.4(cid:160)million
in the same period of 2009. Net charge-offs were $1.4(cid:160)million for the year ended December(cid:160)31,
2009.

Nonperforming Assets

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Nonaccrual loans totaled $10.0(cid:160)million at September(cid:160)30, 2010. This was a $7.3(cid:160)million
increase from $2.7(cid:160)million at December(cid:160)31, 2009. The nonaccrual balance at September(cid:160)30, 2010
primarily consisted of $7.5(cid:160)million in construction and development loans. There were no loans
past due 90 days or more and still accruing interest at September(cid:160)30, 2010. There were four loans
past due 90 days or more with balances of $2.4(cid:160)million at December(cid:160)31, 2009. These loans were
included in the nonaccrual balance of $2.7(cid:160)million.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)We grade loans with a risk grade scale of 1-9, with grades 1-5 representing pass credits, and
grades 6, 7, 8, and 9 representing special mention, substandard, doubtful, and loss credit grades,
respectively. Loans are reviewed on a regular basis internally and annually by an external loan
review group to ensure loans are graded appropriately. Credits are reviewed for past due trends,
declining cash flows, significant decline in collateral value, weakened guarantor financial strength,
management concerns, market conditions, and other factors that could jeopardize the repayment
performance of the loan. Documentation deficiencies to include collateral perfection and outdated
or inadequate financial information are also considered in grading loans.

25

(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)All loans graded 6 or worse are included on our list of watch loans, which is updated and
reported to both the management and board of directors committees and the full board of directors
on a monthly basis. Additionally, other loans with more favorable ratings may be placed on the
watch list if there are concerns that the loan may become a problem in the future. Impairment
analysis has been performed on all loans graded substandard and selected other loans as deemed
appropriate. At September(cid:160)30, 2010, we maintained watch loans totaling $50.9(cid:160)million compared
to $36.6(cid:160)million at December(cid:160)31, 2009. Currently all loans on our watch list carry a risk grade of
6 or worse. The future level of watch loans cannot be predicted, but rather will be determined by
several factors, including overall economic conditions in the markets served.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)At September(cid:160)30, 2010, OREO totaled $1.4(cid:160)million, which represented two residential
lots, four residential properties and one nonresidential property, all of which are recorded based on
our most recent appraisals. At December(cid:160)31, 2009, OREO was $1.5(cid:160)million. All OREO has been
written down to their respective fair values.

Investments and Other Interest-earning Assets

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Investment securities were $115.4(cid:160)million at September(cid:160)30, 2010. This was a $72.8(cid:160)million
increase from the $42.6(cid:160)million balance at December(cid:160)31, 2009 and is a result of investing a portion

EX-99.1

POWERED BY DOCRACY.COM

59

 of 

98

of the proceeds raised in our stock offering. Our investment portfolio consists of U.S. government
agency securities, mortgage-backed securities, municipal securities and other debt instruments. At
the end of the third quarter of 2010, our portfolio had a net unrealized gain of $1.9(cid:160)million
compared to a $0.5(cid:160)million net unrealized gain at December(cid:160)31, 2009. During the nine months
ended September(cid:160)30, 2009, we recorded impairment charges totaling $0.7(cid:160)million related to our
investment in a large correspondent bank, which was taken into receivership by the FDIC. We
have no securities with an unrealized loss deemed to be other than temporary at September(cid:160)30,
2010. In addition, there were no securities with an unrealized loss deemed to be other than
temporary at December(cid:160)31, 2009.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)At September(cid:160)30, 2010, we had $96.6(cid:160)million in federal funds sold, and $5.9(cid:160)million in
interest-bearing deposits with other FDIC insured financial institutions. This compares with $14.0
million in federal funds and $2.8(cid:160)million in interest-bearing deposits at other FDIC insured
financial institutions at December(cid:160)31, 2009.

Deposits and Other Borrowings

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Total deposits increased by $24.5(cid:160)million or 6.2% from December(cid:160)31, 2009 to
September(cid:160)30, 2010. Core deposits (excluding brokered time deposits) increased $41.9(cid:160)million or
16.3%, while brokered time deposits decreased by $17.4(cid:160)million or 12.9%. The increase in core
deposits resulted from a continued effort by management to obtain additional deposits from existing
relationships and stockholders along with targeted calling efforts by associates and board members.
In addition, incentive plans were amended, during 2009 to reward associates for non-time deposit
growth, and to eliminate awards related to loan growth. Consistent with our goal of reducing
reliance on brokered deposits, this effort allowed us to reduce brokered deposits during the year,
from $134.9(cid:160)million at December(cid:160)31, 2009 to $117.5(cid:160)million at September(cid:160)30, 2010, lowering
our wholesale funding to total liabilities from 37.4% at December(cid:160)31, 2009 to 30.5% at
September(cid:160)30, 2010.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Borrowed funds totaled $28.0(cid:160)million at September(cid:160)30, 2010, compared to $33.9(cid:160)million at
December(cid:160)31, 2009.

26

(cid:160)
Results of Operations

Comparison of Results of Operations for the Nine Months Ended September(cid:160)30, 2010 and
September(cid:160)30, 2009

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following table summarizes components of income and expense and the changes in
those components for the nine months ended September(cid:160)30, 2010 and 2009:

Condensed Statements of Income (Loss)

EX-99.1

POWERED BY DOCRACY.COM

60

 of 

98

(cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Nine Months

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160)
(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

Ended

(cid:160) September 30, (cid:160)
(cid:160) 2010
(cid:160)
(cid:160)
(cid:160) (Unaudited)
(cid:160) (Dollars in
(cid:160)
thousands)

(cid:160)

(cid:160) (cid:160)
(cid:160) 2009 (cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) $

Change (cid:160)
(cid:160)
%

Gross interest
income

Gross interest
expense

(cid:160)

Net interest
income

(cid:160)

Provision for loan
losses

(cid:160)

Non-interest
income

Non-interest
expense

(cid:160)

Net income
(loss)(cid:160)before taxes

(cid:160)

Income tax
expense (benefit)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

16,848 (cid:160) (cid:160)

$ 16,008 (cid:160)

(cid:160) $ 840

(cid:160) (cid:160) (cid:160) 5.2

%

5,711 (cid:160) (cid:160)

(cid:160) 7,269 (cid:160)

(cid:160) (cid:160) (1,558 ) (cid:160) (cid:160) -21.4 %

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

11,137 (cid:160) (cid:160)

(cid:160) 8,739 (cid:160)

(cid:160) (cid:160) 2,398 (cid:160) (cid:160) (cid:160) 27.4 %

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

8,768 (cid:160) (cid:160)

(cid:160) 1,854 (cid:160)

(cid:160) (cid:160) 6,914 (cid:160) (cid:160) (cid:160) 372.9 %

(cid:160)

88

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (299

(cid:160)

)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 387

(cid:160) (cid:160) (cid:160) -129.4 %

7,510 (cid:160) (cid:160)

(cid:160) 5,917 (cid:160)

(cid:160) (cid:160) 1,593 (cid:160) (cid:160) (cid:160) 26.9 %

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(5,053 ) (cid:160)

(cid:160) 669

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(1,714 ) (cid:160)

(cid:160) 210

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (5,721 ) (cid:160) (cid:160) -855.2 %

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (1,924 ) (cid:160) (cid:160) -916.2 %

EX-99.1

POWERED BY DOCRACY.COM

61

 of 

98

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Net income (loss) (cid:160) $

(3,339 ) (cid:160)

$ 459

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) $ (3,798 ) (cid:160) (cid:160) -827.5 %

(cid:160) (cid:160) (cid:160)

(cid:160)

Net Income (Loss).

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
 The net loss for the nine months ended September(cid:160)30, 2010 was $3.3
million compared to net income of $0.5(cid:160)million for the same period in 2009. This decrease of
$3.8(cid:160)million resulted primarily from a $6.9(cid:160)million increase in provision for loan losses and an
increase in noninterest expense of $1.6(cid:160)million, which offset increases in net interest income of
$2.4(cid:160)million and noninterest income of $0.4(cid:160)million. A $1.7(cid:160)million tax benefit was recorded
resulting from the increase in the provision for loan losses. Annualized return on average assets
decreased during the nine months ended September(cid:160)30, 2010 to .88)% from .13% for the same
period ended September(cid:160)30, 2009. Annualized return on average equity also decreased from 1.34%
for the nine month period ended September(cid:160)30, 2009 to (6.39)% for the same period in 2010.

Net Interest Income.

 Our largest source of earnings is net interest income, which is the

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
difference between interest income on interest-earning assets and interest paid on deposits and
other interest-bearing liabilities. The primary factors that affect net interest income are changes in
volume and yields of earning assets and interest-bearing liabilities, which are affected in part by
managements responses to changes in interest rates through asset/liability management. During the
nine month period ended September(cid:160)30, 2010, net interest income was $11.1(cid:160)million as compared
to $8.7(cid:160)million in 2009, an increase of $2.4(cid:160)million or 27.5%. In spite of the declining economy,
we experienced growth in the average balances of interest-earning assets arising from growth
related to local loan demand and increases in federal funds sold and investment securities
available-for-sale. Total average interest-earning assets increased by $44.5(cid:160)million, or 10.0%, to
$488.5(cid:160)million for the nine months ended September(cid:160)30, 2010 from $444.0(cid:160)million for the same
period in the previous year. Average loan balances increased by $11.0(cid:160)million, or 2.8%, to
$398.4(cid:160)million for the nine months ended September(cid:160)30, 2010 from $387.4(cid:160)million for the nine
months ended September(cid:160)30, 2009. As a result of the proceeds received in our stock offering, the
average balance of federal funds sold increased $17.2(cid:160)million along with an increase in average
balance of investment securities available-for-sale of $13.7(cid:160)million.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The final month of recognizing income from unwinding our first interest swap was recorded
in June(cid:160)2010. This results in decreasing our net interest margin by approximately 18 basis points a
month.

27

(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Average balances of total interest-bearing liabilities also increased in the first nine months of

EX-99.1

POWERED BY DOCRACY.COM

62

 of 

98

2010, with average total interest-earning deposit balances increasing by $18.8(cid:160)million, or 5.0%, to
$403.4(cid:160)million in 2010 from $384.6(cid:160)million for the same period in 2009. Average brokered
deposits declined by $37.2(cid:160)million from the previous year as management reduced the Banks
wholesale funding. This decline in brokered deposits was more than offset by an increase in average
core deposits of $62.7(cid:160)million in the first nine months of 2010 as compared to the same period in
2009. Average noninterest-bearing deposits increased $8.2(cid:160)million, or 40.0%, to $28.6(cid:160)million at
September(cid:160)30, 2010. Our net interest margin increased from 2.62% in the nine month period
ended September(cid:160)30, 2009 to 3.04% in same period in 2010. Interest paid on funding sources for
the nine months ended September(cid:160)30, 2010 totaled $5.7(cid:160)million, reflecting a 1.89% cost of
interest-bearing liabilities. For the same period in 2009, interest of $7.3(cid:160)million was paid at a cost
of interest-bearing liabilities of 2.52%.

28

(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following tables summarize net interest income and average yields and rates paid for the
periods indicated:

Average Balance Sheets and Net Interest Analysis

(cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) For the

Nine
Months
Ended
September
30,

(cid:160) 2010
(cid:160) Average
(cid:160) Balance
(cid:160) (cid:160)

Assets

Interest-earning
assets:

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) 2009
(cid:160) Income/ (cid:160) (cid:160)
(cid:160) Expense (cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)

Yield/ (cid:160) (cid:160)
(cid:160) (cid:160)
Rate
(cid:160)
(cid:160) (Dollars in
thousands)

Average
Balance
(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

5.11

0.23

Loans with fees (1) (cid:160) $

398,381 (cid:160) (cid:160)

$ 15,275 (cid:160)

Fed funds sold

(cid:160) (cid:160)

34,358 (cid:160) (cid:160)

(cid:160) 60

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

63

 of 

98

Investment
securities  taxable

Investment
securities 
tax-exempt

Other
interest-earning
assets

(cid:160)

Total
interest-earning
assets

Allowance for loan
losses

Cash and due from
banks

Premises and
equipment

Other assets

(cid:160)

Total assets

(cid:160)

(cid:160)

Liabilities and
stockholders
equity

Interest-bearing
liabilities:

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

3.67

4.48

(cid:160) (cid:160)

1.17

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

4.60

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

35,664 (cid:160) (cid:160)

(cid:160) 981

14,304 (cid:160) (cid:160)

(cid:160) 481

(cid:160) (cid:160)

5,832

(cid:160) (cid:160)

(cid:160) 51

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

488,539 (cid:160) (cid:160)

(cid:160) 16,848 (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(8,408

) (cid:160)

7,908

(cid:160) (cid:160)

4,619

(cid:160) (cid:160)

10,446 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

503,104 (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

64

 of 

98

Interest-bearing
demand

Savings and money
market

(cid:160) $

(cid:160) (cid:160)

9,433

(cid:160) (cid:160)

$ 6

46,039 (cid:160) (cid:160)

(cid:160) 270

(cid:160)

(cid:160)

Time deposits  core (cid:160) (cid:160)

186,272 (cid:160) (cid:160)

(cid:160) 2,718 (cid:160)

Other borrowings

(cid:160) (cid:160)

8,747

(cid:160) (cid:160)

130,114 (cid:160) (cid:160)

(cid:160) 1,716 (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

371,858 (cid:160) (cid:160)

(cid:160) 4,710 (cid:160)

22,820 (cid:160) (cid:160)

(cid:160) 430

(cid:160)

(cid:160)

(cid:160)

(cid:160) 571

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

31,567 (cid:160) (cid:160)

(cid:160) 1,001 (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

403,425 (cid:160) (cid:160)

(cid:160) 5,711 (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Time deposits 
brokered

(cid:160)

Total
interest-bearing
deposits

Federal Home Loan
Bank advances

(cid:160) (cid:160)

(cid:160)

Total borrowed
funds

(cid:160)

Total
interest-bearing
liabilities

(cid:160)

Net interest rate
spread

(cid:160)

Noninterest-bearing
demand deposits

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Other liabilities

(cid:160) (cid:160)

1,475

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

28,571 (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) 11,137 (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

65

 of 

98

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

0.08

0.78

1.95

1.76

(cid:160)

1.69

2.51

8.70

(cid:160)

4.23

(cid:160)

1.89

(cid:160)

2.71

(cid:160)

(cid:160)

(cid:160)

Stockholders equity (cid:160) (cid:160)

69,633 (cid:160) (cid:160)

(cid:160)

Total liabilities and
stockholders equity

(cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

Net interest margin (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

503,104 (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

3.04

(cid:160)

 Our provision for loan losses increased $6.9(cid:160)million, or 372.9%, to

(cid:160) Average loan balances include nonaccrual loans.
Provision for Loan Losses.

(1)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
$8.8(cid:160)million during the nine months ended September(cid:160)30, 2010, from $1.9(cid:160)million during the
corresponding period in 2009. The increase in the provision resulted from the credit deterioration
due to the continuing softening economy and a refinement to our allowance for loan loss
methodology, which introduced a more comprehensive qualitative component. We had
$3.0(cid:160)million in net charge-offs during the first nine months of 2010, compared to $0.04(cid:160)million
during 2009. Nonperforming loans to total assets were 1.59% at September(cid:160)30, 2010, compared to
.02% at September(cid:160)30, 2009.

29

(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The ratio of the allowance for loan losses to total loans was 3.31% and 1.79% at
September(cid:160)30, 2010 and 2009, respectively. At December(cid:160)31, 2009, the ratio was 1.86%.
Management periodically evaluates our credit policies and procedures to confirm that they
effectively manage risk and facilitate appropriate internal controls.

Noninterest Income.

 Noninterest income has not historically been a major component of our
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
earnings. We strive for a high level of efficiency by incurring minimal overhead and focusing our
earnings primarily on our core business, earning net interest income on interest-earning assets. We
have a minimal amount of noninterest income from service charges. Noninterest income increased
from a loss of $0.3(cid:160)million for the nine months ended September(cid:160)30, 2009 to a gain of
$0.09(cid:160)million for the same period in 2010. This increase was due mainly to the sale of
available-for-sale securities for a $0.3(cid:160)million gain, offset by an impairment write down of $0.7
million in the nine months ended September(cid:160)30, 2009 compared to the sale and calls of
available-for-sale securities resulting in a net gain of $0.02(cid:160)million during the same period in 2010.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 

Noninterest Expense.

 We actively manage our noninterest expense, since the level of

EX-99.1

POWERED BY DOCRACY.COM

66

 of 

98

noninterest expense substantially affects our profitability. Total noninterest expense was $7.5
million for the nine months ended September(cid:160)30, 2010 compared to $5.9(cid:160)million for the same
period in 2009. The increase of $1.6(cid:160)million, or 26.9%, in the nine months ended September(cid:160)30,
2010 compared to 2009 consists of an increase in salaries and benefits in the amount of
$0.8(cid:160)million as a result of an increase in full time equivalent employees (FTEs). We employed 54
FTEs at September(cid:160)30, 2010 compared to 41 at September(cid:160)30, 2009. In addition, director fees
were paid for the first time during 2010 in the amount of $0.2(cid:160)million and OREO expense
increased $0.2(cid:160)million primarily due to a $0.3(cid:160)million loss in sales of OREO property. Lastly,
other expenses included increases in professional fees, postage and supplies and loan collection fees.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following table presents components of noninterest expense for the nine months ended
September(cid:160)30, 2010 and 2009:

Noninterest Expense

EX-99.1

POWERED BY DOCRACY.COM

67

 of 

98

(cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Nine months

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160)
(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

ended

(cid:160) September 30, (cid:160)
(cid:160)
(cid:160) 2010
(cid:160)
(cid:160) (Unaudited)
(cid:160) (Dollars in
(cid:160)
thousands)

(cid:160)

(cid:160) (cid:160)
(cid:160) 2009 (cid:160) (cid:160)
(cid:160) $
(cid:160) (cid:160)

Change (cid:160)
%
(cid:160)

Salaries and benefits

(cid:160) $

4,328 (cid:160) (cid:160)

$ 3,558 (cid:160)

(cid:160) $ 770

(cid:160) (cid:160) (cid:160) 21.6 %

Occupancy and
equipment

Advertising and
marketing

Professional fees

Deposit charges and
FDIC insurance

Directors fees

Data processing

Other real estate
owned

Other expenses

(cid:160)

(cid:160)

Total noninterest
expense

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

666

(cid:160) (cid:160)

(cid:160) 625

(cid:160)

(cid:160) (cid:160) 41

(cid:160) (cid:160) (cid:160) 6.6 %

237

(cid:160) (cid:160)

(cid:160) 174

(cid:160)

(cid:160) (cid:160) 63

(cid:160) (cid:160) (cid:160) 36.2 %

237

(cid:160) (cid:160)

(cid:160) 160

543

(cid:160) (cid:160)

(cid:160) 590

211

(cid:160) (cid:160)

(cid:160)

302

(cid:160) (cid:160)

(cid:160) 299

395

(cid:160) (cid:160)

(cid:160) 157

591

(cid:160) (cid:160)

(cid:160) 354

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) 77

(cid:160) (cid:160) (cid:160) 48.1 %

(cid:160) (cid:160) (47

) (cid:160) (cid:160) -8.0 %

(cid:160) (cid:160) 211

(cid:160) (cid:160) (cid:160) 100.0 %

(cid:160) (cid:160) 3

(cid:160) (cid:160) (cid:160) 1.0 %

(cid:160) (cid:160) 238

(cid:160) (cid:160) (cid:160) 151.6 %

(cid:160) (cid:160) 237

(cid:160) (cid:160) (cid:160) 66.9 %

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

7,510 (cid:160) (cid:160)

$ 5,917 (cid:160)

(cid:160) $ 1,593 (cid:160) (cid:160) (cid:160) 26.9 %

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

Income Taxes.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
 We generate significant amounts of non-taxable income from tax-exempt
investment securities. Accordingly, the level of such income in relation to income before taxes

EX-99.1

POWERED BY DOCRACY.COM

68

 of 

98

significantly affects our effective tax rate. For the nine months ended September(cid:160)30, 2010, we
booked an income tax benefit of $1.7(cid:160)million compared to an income tax expense of $0.2(cid:160)million
for the same period in 2009. The effective tax rate for the nine months ended September(cid:160)30, 2010
is 40.15% compared to 31.28% for the same period in 2009. This increase was due to a loss of tax
benefits, used in calculating our tax provision, resulting from us reporting a loss. A tax benefit is
recorded if non-taxable income exceeds income before taxes, resulting in a reduction of total
income subject to income taxes.

30

(cid:160)
Comparison of Results of Operations for the Three Months Ended September(cid:160)30, 2010 and 2009

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following table summarizes components of income and expense and changes in those
components for the three months ended September(cid:160)30, 2010 and 2009:

Condensed Statements of Income (Loss)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160)
(cid:160) Three

Months
Ended

(cid:160) September

(cid:160)

(cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)
(cid:160)
(cid:160)

Gross
interest
income

Gross
interest
expense

(cid:160)

Net interest
income

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

30,

(cid:160)
(cid:160) 2010
(cid:160) (Unaudited) (cid:160)
(cid:160) (cid:160)
(cid:160)

5,559 (cid:160) (cid:160)

(cid:160) 2009 (cid:160)
(cid:160)
(cid:160) $
(Dollars in
(cid:160) (cid:160)
thousands)
$

(cid:160)
(cid:160)
(cid:160)

Change (cid:160)
(cid:160)
%
(cid:160)
(cid:160) (cid:160) (cid:160)

5,568 (cid:160)

(cid:160) $ (9

) (cid:160) (cid:160) -0.2

%

1,929 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

3,630 (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

2,283 (cid:160)

(cid:160) (cid:160) (354

) (cid:160) (cid:160) -15.5 %

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

3,285 (cid:160)

(cid:160) (cid:160) 345

(cid:160) (cid:160) (cid:160) 10.5

%

EX-99.1

POWERED BY DOCRACY.COM

69

 of 

98

(cid:160)

Provision
for loan
losses

(cid:160)

Noninterest
income

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Noninterest
expense

(cid:160) (cid:160)

(cid:160)

Net income
(loss)(cid:160)before
taxes

(cid:160)

Income tax
expense
(benefit)

(cid:160)

(cid:160)

Net income
(loss)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

6,143 (cid:160) (cid:160)

(cid:160)

26

(cid:160) (cid:160)

(cid:160) (cid:160)

2,990 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(5,477 ) (cid:160)

(cid:160)

(cid:160) (cid:160)

(1,809 ) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(3,668 ) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

$

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

1,150 (cid:160)

(cid:160) (cid:160) 4,993 (cid:160) (cid:160) (cid:160) 434.2 %

(cid:160)

26

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) 0.0

(cid:160)

%

2,018 (cid:160)

(cid:160) (cid:160) 972

(cid:160) (cid:160) (cid:160) 48.2

%

(cid:160)

143

(cid:160)

27

(cid:160)

(cid:160)

116

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (5,620 ) (cid:160) (cid:160) -3930.1 %

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (1,836 ) (cid:160) (cid:160) -6800.0 %

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) $ (3,784 ) (cid:160) (cid:160) -3262.1 %

(cid:160) (cid:160) (cid:160)

(cid:160)

Net Income.

 Net loss for the quarter ended September(cid:160)30, 2010 was $3.7(cid:160)million as

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
compared to net income of $0.1(cid:160)million for the same period in 2009. This decrease of
$3.8(cid:160)million primarily resulted from a $5.0(cid:160)million increase in provision for loan losses and an
increase in noninterest expense of $1.0(cid:160)million, which was partially offset by an increase in net
interest income of $0.3(cid:160)million. Annualized return on average assets decreased to (2.64)% for the
three month period ended September(cid:160)30, 2010 from .10% for the same period in 2009. Return on
average equity decreased from 1.01% for the three month period ended September(cid:160)30, 2009 to
(12.80)% for the same period in 2010.

EX-99.1

POWERED BY DOCRACY.COM

70

 of 

98

Net Interest Income

. During the three month period ended September(cid:160)30, 2010, net interest

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
income was $3.6(cid:160)million as compared to $3.3(cid:160)million in 2009, an increase of $0.3(cid:160)million or
10.5%. In spite of the declining economy, we experienced growth in the average balances of
interest-earning assets arising primarily from growth related to local loan demand. Average total
interest-earning assets increased by $83.6(cid:160)million, or 18.2%, to $542.1(cid:160)million for the three
months ended September(cid:160)30, 2010 from $458.5(cid:160)million for the same period in the previous year.
Most of the growth occurred in loans, with average loan balances increasing by $8.7(cid:160)million, or
2.2%, to $399.6(cid:160)million for the three months ended September(cid:160)30, 2010 from $390.9(cid:160)million for
the three months ended September(cid:160)30, 2009.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The final month of recognizing income from unwinding our first interest rate swap was
recorded in June(cid:160)2010. This results in decreasing our net interest margin by approximately 18 basis
points a month.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Average balances of total interest-bearing liabilities also increased the third quarter of 2010,
with average total interest-earning deposit balances increasing by $14.2(cid:160)million, or 3.9%, to
$408.0(cid:160)million in 2010 from $359.8(cid:160)million for the same period in 2009. Average core time
deposits increased from $156.9(cid:160)million at September(cid:160)30, 2009 to $192.7(cid:160)million at September(cid:160)30,
2010, a $35.8(cid:160)million, or 22.8% increase. Average brokered deposits on the other hand, decreased
$32.5(cid:160)million or 20.6% during the same period as management reduced the Banks wholesale
funding. Average noninterest-bearing deposits increased $8.2(cid:160)million, or 36.5% in the third quarter
of 2010 compared to the same period in 2009, and interest-bearing demand, money market and
savings deposits,

31

(cid:160)
increased $11.0(cid:160)million, or 21.4%. Our net interest margin decreased from 2.87% at
September(cid:160)30, 2009 to 2.68% at September(cid:160)30, 2010.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following tables summarize net interest income and average yields and rates paid for the
periods indicated:

Average Balance Sheets and Net Interest Analysis

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) For the

(cid:160)
(cid:160)

Three
Months
Ended
September
30,

EX-99.1

POWERED BY DOCRACY.COM

71

 of 

98

2009 (cid:160)
(cid:160)
(cid:160)

Income/ (cid:160) (cid:160)
Expense (cid:160) (cid:160)

Yield/ (cid:160) (cid:160) Average (cid:160) (cid:160) Income/
Rate
(cid:160) (cid:160) Balance (cid:160) (cid:160) Expense

(cid:160)

(cid:160)

399,580 (cid:160)

70,388 (cid:160)

50,216 (cid:160)

14,570 (cid:160)

(cid:160) (cid:160)

7,350

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

542,104 (cid:160)

(9,061

)

8,056

4,596

9,960

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

$ 4,963 (cid:160)

(cid:160) (cid:160) 4.97

% (cid:160) $

(cid:160) 42

(cid:160) 370

(cid:160)

(cid:160)

(cid:160) (cid:160) 0.24

% (cid:160) (cid:160)

(cid:160) (cid:160) 2.95

% (cid:160) (cid:160)

(cid:160) 161

(cid:160)

(cid:160) (cid:160) 4.42

% (cid:160) (cid:160)

(cid:160) 23

(cid:160)

(cid:160) (cid:160) 1.25

% (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) 5,559 (cid:160)

(cid:160) (cid:160) 4.10

% (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160) 2010
(cid:160) Average
(cid:160) Balance
(cid:160) (Dollars in
thousands)

Assets

Interest-earning
assets:

(cid:160) (cid:160)

(cid:160) (cid:160)

Loans with fees (1) (cid:160) $

(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Fed funds sold

Investment
securities  taxable

Investment
securities 
tax-exempt

Other
interest-earning
assets

(cid:160)

Total
interest-earning
assets

Allowance for loan
losses

Cash and due from
banks

Premises and
equipment

Other assets

EX-99.1

POWERED BY DOCRACY.COM

72

 of 

98

(cid:160)

Total assets

(cid:160)

(cid:160)

Liabilities and
stockholders
equity

Interest-bearing
liabilities:

Interest-bearing
demand

Savings and money
market

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

Time deposits  core (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Time deposits 
brokered

(cid:160)

Total
interest-bearing
deposits

Federal Home Loan
Bank advances

(cid:160) (cid:160)

Other borrowings

(cid:160) (cid:160)

(cid:160)

Total borrowed
funds

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

555,655 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

9,695

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

52,138 (cid:160)

192,666 (cid:160)

125,007 (cid:160)

(cid:160)

(cid:160)

379,506 (cid:160)

20,000 (cid:160)

8,490

(cid:160)

(cid:160)

(cid:160)

28,490 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

$ 3

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) $

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 0.12

% (cid:160) $

(cid:160) 102

(cid:160)

(cid:160) (cid:160) 0.78

% (cid:160) (cid:160)

(cid:160) 909

(cid:160) 581

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) 1.89

% (cid:160) (cid:160)

(cid:160) (cid:160) 1.86

% (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) 1,595 (cid:160)

(cid:160) (cid:160) 1.68

% (cid:160) (cid:160)

(cid:160) 144

(cid:160)

(cid:160) (cid:160) 2.88

% (cid:160) (cid:160)

(cid:160) 190

(cid:160) (cid:160)

(cid:160) 334

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) 8.95

% (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 4.69

% (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

73

 of 

98

Total
interest-bearing
liabilities

(cid:160)

Net interest rate
spread

(cid:160)

Noninterest-bearing
demand deposits

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Other liabilities

(cid:160) (cid:160)

Stockholders equity (cid:160) (cid:160)

(cid:160)

Total liabilities and
stockholders equity

(cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

Net interest margin (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

407,996 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) 1,929 (cid:160)

(cid:160) (cid:160) 1.89

% (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) 3,630 (cid:160)

(cid:160) (cid:160) 2.21

% (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) $

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 2.68

% (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

30,828 (cid:160)

2,168

(cid:160)

114,663 (cid:160)

(cid:160)

(cid:160)

555,655 (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) Average loan balances include nonaccrual loans.

(1)
Provision for Loan Losses.
 Our provision for loan losses increased $5.0(cid:160)million, or 434.2%, to
$6.1(cid:160)million during the quarter ended September(cid:160)30, 2010, from $1.2(cid:160)million during the
corresponding period in 2009. The increase in provision was due to credit deterioration due to the
continuing soft economy and a refinement to our allowance for loan loss methodology. We
recorded $2.0(cid:160)million in net charge-offs for the three months ended September(cid:160)30, 2010
compared to $0.4 million for the same period in 2009. For the quarter ended September(cid:160)30, 2010,
our nonaccrual loans increased by $3.5(cid:160)million compared to $1.3(cid:160)million in the quarter ended
September(cid:160)30, 2009.

32

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

74

 of 

98

Noninterest Income.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
months ended September(cid:160)30, 2010 and 2009.

 Total noninterest income remained flat at $0.3(cid:160)million for the three

Noninterest Expense.

 Total noninterest expense was $3.0(cid:160)million for the three months ended

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
September(cid:160)30, 2010 compared to $2.0(cid:160)million for the same period in 2009. This increase of
$1.0(cid:160)million, or 48.2%, principally reflects increases in personnel costs, an increase in loan and loan
collection fees resulting from bankruptcies and an increase in other expenses of $.02(cid:160)million
resulting from the payment of director fees in 2010, education, and our NC Bank Assessment
partially offset by a decrease in FDIC insurance due to a special assessment charged in 2009.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following table presents components of noninterest expense for the quarters ended
September(cid:160)30, 2010 and 2009:

Noninterest Expense

EX-99.1

POWERED BY DOCRACY.COM

75

 of 

98

(cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) Three months

(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160) (cid:160)
(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

ended

(cid:160) September 30, (cid:160)
(cid:160)
(cid:160) 2010
(cid:160)
(cid:160) (Unaudited)
(cid:160) (Dollars in
(cid:160)
thousands)

(cid:160)

(cid:160) (cid:160)
(cid:160) 2009 (cid:160) (cid:160)
(cid:160) $
(cid:160) (cid:160)

Change (cid:160)
%
(cid:160)

Salaries and benefits

Occupancy and
equipment

Advertising and
marketing

Professional fees

Deposit charges and
FDIC insurance

Directors fees

Data processing

Other expenses

(cid:160)

(cid:160)

Total noninterest
expense

(cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

1,777 (cid:160) (cid:160)

$ 1,182 (cid:160)

(cid:160) $ 595 (cid:160) (cid:160) (cid:160) 50.3 %

236

(cid:160) (cid:160)

(cid:160) 212

(cid:160)

(cid:160) (cid:160) 24 (cid:160) (cid:160) (cid:160) 11.3 %

84

(cid:160) (cid:160)

(cid:160) 84

78

(cid:160) (cid:160)

(cid:160) 54

184

(cid:160) (cid:160)

(cid:160) 230

164

(cid:160) (cid:160)

(cid:160)

109

(cid:160) (cid:160)

(cid:160) 97

358

(cid:160) (cid:160)

(cid:160) 159

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) 0.0 %

(cid:160) (cid:160) 24 (cid:160) (cid:160) (cid:160) 44.4 %

(cid:160) (cid:160) (46 ) (cid:160) (cid:160) -20.0 %

(cid:160) (cid:160) 164 (cid:160) (cid:160) (cid:160) 100.0 %

(cid:160) (cid:160) 12 (cid:160) (cid:160) (cid:160) 12.4 %

(cid:160) (cid:160) 199 (cid:160) (cid:160) (cid:160) 125.2 %

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160) (cid:160)

(cid:160)

2,990 (cid:160) (cid:160)

$ 2,018 (cid:160)

(cid:160) $ 972 (cid:160) (cid:160) (cid:160) 48.2 %

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

Income taxes.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) 
 We recorded an income tax benefit for the third quarter of 2010 of $1.8
million compared to an income tax expense of $0.02(cid:160)million for the third quarter of 2009.

Liquidity and Capital Resources

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Liquidity refers to the ability to manage future cash flows to meet the needs of depositors and

EX-99.1

POWERED BY DOCRACY.COM

76

 of 

98

borrowers and to fund operations. Management strives to maintain sufficient liquidity to fund
future loan demand and to satisfy fluctuations in deposit levels. This is achieved primarily in the
form of available lines of credit from various correspondent banks, the FHLB, the Federal Reserve
Discount Window, and through an investment portfolio. In addition, we occasionally have
short-term investments at our primary correspondent bank in the form of federal funds sold.
Liquidity is governed by a board of directors approved Asset Liability Policy, administered by an
internal Senior Management Risk Committee. The Committee reports on a monthly basis
asset/liability (ALCO)-related matters to the Board of Directors Loan and Risk Committee. During
2009, the Bank adopted a Contingency Funding Plan to address liquidity needs in the time of an
unforeseen crisis.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Our liquidity ratio was 54.99% at September(cid:160)30, 2010 compared to 16.31% at
December(cid:160)31, 2009, in each case exceeding our minimum internal target of 10%. In addition, at
September(cid:160)30, 2010, we had an additional $20.0(cid:160)million of credit available from the FHLB,
$41.0(cid:160)million from the Federal Reserve Discount Window, and available lines of credit totaling
$38.0(cid:160)million from correspondent banks.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)At September(cid:160)30, 2010, we had $9.0(cid:160)million of loan commitments outstanding and had
pre-approved but unused lines of credit totaling $67.2(cid:160)million. In managements opinion, these
commitments represent no more than normal lending risk to the Bank and will be funded from
normal sources of liquidity. At December(cid:160)31, 2009, we

33

(cid:160)
had $6.3(cid:160)million of loan commitments outstanding and had pre-approved but unused lines of
credit totaling $70.9(cid:160)million.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Our capital position is reflected in our stockholders equity, subject to certain adjustments for
regulatory purposes. Stockholders equity, or capital, is a measure of our net worth, soundness and
viability. Stockholders equity on September(cid:160)30, 2010 was $183.8(cid:160)million compared to the
December(cid:160)31, 2009 balance of $46.1(cid:160)million. In August(cid:160)2010, we completed our public offering
of 23,100,000 shares of common stock at an initial purchase price of $6.50 per share for an
aggregate offering price of approximately $150.2(cid:160)million. As a result of the offering, we received
net proceeds of approximately $140.2(cid:160)million, after $9.0(cid:160)million in underwriting fees, including
the $3.0(cid:160)million in contingent fees (See Note 3), and approximately $0.9(cid:160)million in related
expenses. Remaining proceeds have been invested in accordance with the Banks investment
policies.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Risk based capital regulations adopted by the FDIC require banks to achieve and maintain
specified ratios of capital to risk weighted assets. The risk based capital rules are designed to measure
Tier 1 capital (consisting of common equity, retained earnings and a limited amount of qualifying
perpetual preferred stock and trust preferred securities, net of goodwill and other intangible assets

EX-99.1

POWERED BY DOCRACY.COM

77

 of 

98

and accumulated other comprehensive income) and total capital in relation to the credit risk of
both on- and off-balance sheet items. Under the guidelines, one of four risk weights is applied to
the different on-balance sheet items. Off-balance sheet items, such as loan commitments, are also
subject to risk weighting after conversion to balance sheet equivalent amounts. All banks must
maintain a minimum total capital to total risk weighted assets ratio of 8.00%, at least half of which
must be in the form of core, or Tier 1, capital. These guidelines also specify that banks that are
experiencing internal growth or making acquisitions will be expected to maintain capital positions
substantially above the minimum supervisory levels. At September(cid:160)30, 2010, we satisfied the
respective minimum regulatory capital requirements, and we were well capitalized within the
meaning of federal regulatory requirements. Our risk-weighted assets at September(cid:160)30, 2010 and
December(cid:160)31, 2009 were $423.0(cid:160)million and $421.1(cid:160)million, respectively. Actual capital levels
and minimum levels at September(cid:160)30, 2010 and December(cid:160)31, 2009 were:

Capital Ratios

EX-99.1

POWERED BY DOCRACY.COM

78

 of 

98

(cid:160)
(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Actual
(cid:160) Amount
(cid:160) (Dollars in
thousands)

September(cid:160)30,
2010

(cid:160) (cid:160)

(cid:160)
(cid:160)
(cid:160)
(cid:160)
(cid:160)

(cid:160)

(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Capitalized (cid:160) (cid:160)
(cid:160) (cid:160)
(cid:160) Ratio

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

Total
Risk-Based
Capital Ratio

(cid:160)

Tier 1 Capital
Ratio

(cid:160)

Tier 1 Leverage
Ratio

(cid:160)

December(cid:160)31,
2009

Total
Risk-Based
Capital Ratio

(cid:160)

Tier 1 Capital
Ratio

(cid:160)

Tier 1 Leverage
Ratio

(cid:160) $

194,514 (cid:160) (cid:160)

(cid:160) 45.99 %

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

182,235 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

182,235 (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) 43.09 %

(cid:160) (cid:160)

(cid:160)

(cid:160) 32.80 %

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

57,061 (cid:160) (cid:160)

(cid:160) 13.55 %

(cid:160)

(cid:160) (cid:160)

44,877 (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

44,877 (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) 10.66 %

(cid:160) (cid:160)

(cid:160)

(cid:160) 9.40 %

(cid:160) (cid:160)
(cid:160)
(cid:160) Adequately (cid:160)

(cid:160)
(cid:160)
Capitalized (cid:160)
Ratio

(cid:160) (cid:160)

Ratio

(cid:160)

8.00

(cid:160)

4.00

(cid:160)

4.00

(cid:160)

(cid:160)

8.00

(cid:160)

4.00

(cid:160)

4.00

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The Bank has committed to our regulators to maintain a ratio of Tier 1 Leverage Ratio of at

EX-99.1

POWERED BY DOCRACY.COM

79

 of 

98

least 10.00% for the three years following our initial public offering.

Disclosure of Contractual Obligations, Commitments and Off-Balance Sheet
Arrangements

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In the ordinary course of operations, we enter into certain contractual obligations. Such
obligations include the funding of operations through debt issuances as well as leases for premises
and equipment.

34

(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Information about our off-balance sheet risk exposure is presented in Note K of our audited
financial statements included in the Registration Statement. As part of ongoing business, we do not
participate in transactions that generate relationships with unconsolidated entities or financial
partnerships, such as entities often referred to as special purpose entities (SPEs), which generally are
established for facilitating off-balance sheet arrangements or other contractually narrow or limited
purposes. As of September(cid:160)30, 2010, we were not involved in any unconsolidated SPE
transactions.

Interest Rate Sensitivity

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Our Senior Management Risk Committee actively measures and manages interest rate risk
using a process developed by the Bank. The Committee is also responsible for approving our
asset/liability management policies, overseeing the formulation and implementation of strategies to
improve balance sheet positioning and earnings, and reviewing our interest rate sensitivity position.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The primary tool that management uses to measure short-term interest rate risk is a net
interest income simulation model prepared by an independent correspondent bank. These
simulations estimate the impact that various changes in the overall level of interest rates over a one
and two year time horizon would have on net interest income. The results help us develop
strategies for managing exposure to interest rate risk.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Like any forecasting technique, interest rate simulation modeling is based on a large number
of assumptions. In this case, the assumptions relate primarily to loan and deposit growth, asset and
liability prepayments, interest rates and balance sheet management strategies. Management believes
that both individually and taken together the assumptions are reasonable. Nevertheless, the
simulation modeling process produces only a sophisticated estimate, not a precise calculation of
exposure. In addition, the overall interest rate risk management process is subject to annual review
by an outside professional services firm to ascertain its effectiveness as required by federal
regulations.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Our current guidelines for risk management call for preventive measures if a 300 basis point
shock or immediate increase or decrease in short term rates over the next 12(cid:160)months would affect
net interest income over the same period by more than 20.0%. We currently are operating well

EX-99.1

POWERED BY DOCRACY.COM

80

 of 

98

within these guidelines. As of September(cid:160)30, 2010, based on the results of the simulation model,
we could expect net interest income to decrease by approximately 4.6% over 12(cid:160)months if
short-term interest rates immediately decreased by 300 basis points, which is unlikely based on
current rate levels. If short-term interest rates increased by 300 basis points, net interest income
could be expected to increase by approximately 17.6% over 12(cid:160)months. At December(cid:160)31, 2009,
the simulation model results showed that we could expect net interest income to decrease by
approximately 2.9% over 12(cid:160)months if short-term interest rates decreased by 300 basis points. If
short-term interest rates increased by 300 basis points, net interest income could be expected to
increase by approximately 4.6% over 12(cid:160)months.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)We use multiple interest rate swap agreements, accounted for as either cash flow or fair value
hedges, as part of the management of interest rate risk. At September(cid:160)30, 2010, we had an interest
rate swap, accounted for as a cash flow hedge, with a notional amount of $40.0(cid:160)million that was
purchased on May(cid:160)16, 2008 to protect the bank from falling rates. We receive 6.22% fixed for a
period of three years, and pay prime rate for the same period, currently at 3.25%. At September(cid:160)30,
2010, the unrealized gain on this instrument was $0.4(cid:160)million. During the nine months ended
September(cid:160)30, 2010 and 2009, we recorded $0.9(cid:160)million of income from this instrument. The
unrealized gain on this instrument at December(cid:160)31, 2009 was $0.7(cid:160)million.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)During the year ended December(cid:160)31, 2008, we entered into five loan swaps accounted for
as fair value hedges. The total original notional amount of these swaps was $11.2(cid:160)million. These
derivative instruments are used to protect the Bank from interest rate risk caused by changes in the
LIBOR curve in relation to certain designated fixed rate loans. These derivative instruments are
carried at a fair market value of $0.8(cid:160)million at September(cid:160)30, 2010. We recorded interest expense
on these loan swaps of $0.3(cid:160)million for the nine months ended September(cid:160)30, 2010 and 2009.

35

(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In addition, we recorded income on a swap that was terminated in early 2008. During the
nine months ended September(cid:160)30, 2010 and 2009, $0.4(cid:160)million and $0.6(cid:160)million were recorded
as income from this unwound swap, respectively. As of June(cid:160)30, 2010, the unrecognized gain
relating to the unwound hedge has been fully taken into income.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)For cash flow hedges, we use the dollar-offset method for assessing effectiveness using the
cumulative approach. The dollar-offset method compares the dollar amount of the change in
anticipated future cash flows of the hedging instrument with the dollar amount of the changes in
anticipated future cash flows of the risk being hedged over the assessment period. The cumulative
approach involves comparing the cumulative changes in the hedging instruments anticipated future
cash flows to the cumulative changes in the hedged transactions anticipated future cash flows.
Because the floating index and reset dates are based on identical terms, management believes that

EX-99.1

POWERED BY DOCRACY.COM

81

 of 

98

the hedge relationship of the cumulative changes in expected future cash flow from the hedging
derivative and the cumulative changes in expected interest cash flows from the hedged exposure
will be highly effective.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Consistent with the risk management objective and the hedge accounting designation,
management measures the degree of hedge effectiveness by comparing the cumulative change in
anticipated interest cash flows from the hedged exposure over the hedging period to the cumulative
change in anticipated cash flows from the hedging derivative. Any difference between these two
measures will be deemed hedge ineffectiveness and recorded in current earnings. Management
utilizes the Hypothetical Derivative Method to compute the cumulative change in anticipated
interest cash flows from the hedged exposure. To the extent that the cumulative change in
anticipated cash flows from the hedging derivative offsets from 80% to 125% of the cumulative
change in anticipated interest cash flows from the hedged exposure, the hedge is deemed effective.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)For fair value hedges, Accounting Standards Codification (ASC) Topic 815 requires that the
method selected for assessing hedge effectiveness must be reasonable, be defined at the inception of
the hedging relationship and be applied consistently throughout the hedging relationship. We use
the dollar-offset method for assessing effectiveness using the cumulative approach. The dollar-offset
method compares the fair value of the hedging derivative with the fair value of the hedged
exposure. The cumulative approach involves comparing the cumulative changes in the hedging
derivatives fair value to the cumulative changes in the hedged exposures fair value. The calculation
of dollar offset is the change in clean fair value of hedging derivative, divided by the change in fair
value of the hedged exposure attributable to changes in the LIBOR curve. To the extent that the
cumulative change in fair value of the hedging derivative offsets from 80% to 125% of the
cumulative change in fair value of the hedged exposure, the hedge will be deemed effective. The
change in fair value of the hedging derivative and the change in fair value of the hedged exposure
are recorded in earnings. Any hedge ineffectiveness is also reflected in current earnings.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Prime rate swaps (pay floating, received fixed) are recorded on the balance sheet in other
assets or liabilities at fair market value. Loan swaps (pay fixed, receive floating) are carried at fair
market value and are included in loans. Changes in fair value of the hedged loans have been
completely offset by the fair value changes in the derivatives, which are in contra asset accounts
included in loans.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)See Note L of our audited financial statements included in the Registration Statement and
Note 8 of our unaudited condensed financial statements included in this Quarterly Report on Form
10-Q for further discussion on our derivative financial instruments and hedging activities.

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Financial institutions are subject to interest rate risk to the degree that their interest-bearing
liabilities, primarily deposits, mature or reprice more or less frequently, or on a different basis, than
their interest-earning assets, primarily loans and investment securities. The match between the
scheduled repricing and maturities of our interest-earning assets and liabilities within defined
periods is referred to as gap analysis. At September(cid:160)30, 2010, our cumulative one-year gap was a

EX-99.1

POWERED BY DOCRACY.COM

82

 of 

98

positive, or asset sensitive, $111.0(cid:160)million, or 17.5% of total assets, well within our ALCO policy
guideline of 35%. Our cumulative one-year gap at December(cid:160)31, 2009 was a negative
$11.2(cid:160)million or 2.4% of total assets.

36

(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following table reflects our rate sensitive assets and liabilities by maturity as of
September(cid:160)30, 2010. Variable rate loans are shown in the category of due within three months
because they reprice with changes in the prime lending rate. Fixed rate loans are presented
assuming the entire loan matures on the final due date, although payments are actually made at
regular intervals and are not reflected in this schedule.

Interest Rate Gap Sensitivity

(cid:160) (cid:160) (cid:160)
(cid:160) (cid:160) (cid:160)

(cid:160)
One
Year
to
Five
Years (cid:160) (cid:160) Five

(cid:160) (cid:160) After

(cid:160) (cid:160) (cid:160)
(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160) (cid:160) Total (cid:160)

Years

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160) $

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) 49,383 (cid:160) (cid:160) (cid:160)

41,420

(cid:160) (cid:160) 104,283 (cid:160) (cid:160) (cid:160)

1,049

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)
(cid:160) Within

(cid:160) Three

(cid:160) Months

(cid:160) (Dollars in
thousands)

(cid:160) (cid:160)

At
September(cid:160)30,
2010:

Interest-earning
assets:

(cid:160) (cid:160)

Interest-bearing
deposits

(cid:160) $

Federal funds
sold

Securities

Loans

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)
(cid:160) Three

(cid:160) (cid:160)
(cid:160) (cid:160)

(cid:160) Months

(cid:160) (cid:160)

to

(cid:160) One
Year

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

5,859

(cid:160) (cid:160)

96,560 (cid:160) (cid:160)

$

(cid:160)

3,751

(cid:160) (cid:160)

(cid:160) 22,731

262,796 (cid:160) (cid:160)

(cid:160) 29,588

EX-99.1

POWERED BY DOCRACY.COM

83

 of 

98

(cid:160)

Total
interest-earning
assets

(cid:160)

Interest-bearing
liabilities:

Demand
deposits

MMDA and
savings

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

368,966 (cid:160) (cid:160)

(cid:160) 52,319

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

11,959 (cid:160) (cid:160)

60,681 (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 153,666 (cid:160) (cid:160) (cid:160)

42,469

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

Time deposits

(cid:160) (cid:160)

61,025 (cid:160) (cid:160)

(cid:160) 186,212 (cid:160)

(cid:160) (cid:160) 66,805 (cid:160) (cid:160) (cid:160)

1,100

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 20,000 (cid:160) (cid:160) (cid:160)

6,895

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

134,765 (cid:160) (cid:160)

(cid:160) 186,212 (cid:160)

(cid:160) (cid:160) 86,805 (cid:160) (cid:160) (cid:160)

6,895

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(29,317 ) (cid:160)

(cid:160) 40,000

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (10,683 ) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)

204,884 (cid:160) (cid:160)

$ (93,893 )

(cid:160) $ 56,178 (cid:160) (cid:160) $

35,574

204,884 (cid:160) (cid:160)

$ 110,991 (cid:160)

(cid:160) $ 167,169 (cid:160) (cid:160) $

202,743

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) $

Short term
borrowings

Long term
borrowings

(cid:160)

Total
interest-bearing
liabilities

(cid:160)

Derivatives

(cid:160)

Interest
sensitivity gap

Cummulative
interest
sensitivity gap

(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

84

 of 

98

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

Percentage of
total assets

(cid:160)

At
December(cid:160)31,
2009:

Interest-earning
assets:

(cid:160) (cid:160)

Interest bearing
deposits

(cid:160) $

Federal funds
sold

Securities

Loans

(cid:160)

Total
interest-earning
assets

(cid:160)

Interest-bearing
liabilities:

Demand
deposits

MMDA and
savings

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

2,758

(cid:160) (cid:160)

13,975 (cid:160) (cid:160)

$

(cid:160)

1,043

(cid:160) (cid:160)

(cid:160) 6,672

261,122 (cid:160) (cid:160)

(cid:160) 32,645

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

278,898 (cid:160) (cid:160)

(cid:160) 39,317

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

9,650

(cid:160) (cid:160)

42,659 (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) 17.54

%

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160) $

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) 8,213

(cid:160) (cid:160) (cid:160)

28,636

(cid:160) (cid:160) 102,820 (cid:160) (cid:160) (cid:160)

977

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 111,033 (cid:160) (cid:160) (cid:160)

29,613

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

Time deposits

(cid:160) (cid:160)

80,001 (cid:160) (cid:160)

(cid:160) 160,763 (cid:160)

(cid:160) (cid:160) 75,474 (cid:160) (cid:160) (cid:160)

Short term
borrowings

(cid:160) (cid:160)

6,989

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

85

 of 

98

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) $

(cid:160) $

(cid:160) (cid:160)

(cid:160) (cid:160)

Long term
borrowings

(cid:160)

Total
interest-bearing
liabilities

(cid:160)

Derivatives

(cid:160)

Interest
sensitivity gap

Cummulative
interest
sensitivity gap

(cid:160)
Percentage of
total assets

(cid:160)

37

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) 20,000 (cid:160) (cid:160) (cid:160)

6,895

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

139,299 (cid:160) (cid:160)

(cid:160) 160,763 (cid:160)

(cid:160) (cid:160) 95,474 (cid:160) (cid:160) (cid:160)

6,895

(cid:160)

(cid:160) (cid:160)

(29,316 ) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) 32,963 (cid:160) (cid:160) (cid:160)

(3,647

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

110,283 (cid:160) (cid:160)

$ (121,446 )

(cid:160) $ 48,522 (cid:160) (cid:160) $

19,071

110,283 (cid:160) (cid:160)

$ (11,163 )

(cid:160) $ 37,359 (cid:160) (cid:160) $

56,430

(cid:160)

(cid:160)

(cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160) -2.36

%

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160) (cid:160) (cid:160)

(cid:160)

(cid:160)

(cid:160)
Impact of Inflation and Changing Prices

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)A commercial bank has an asset and liability make-up that is distinctly different from that of a
company with substantial investments in plant and inventory because the major portions of a
commercial banks assets are monetary in nature. As a result, a banks performance may be
significantly influenced by changes in interest rates. Although the banking industry is more affected
by changes in interest rates than by inflation in the prices of goods and services, inflation is a factor
that may influence interest rates. However, the frequency and magnitude of interest rate
fluctuations do not necessarily coincide with changes in the general inflation rate. Inflation does
affect operating expenses in that personnel expenses and the cost of supplies and outside services
tend to increase more during periods of high inflation.

38

EX-99.1

POWERED BY DOCRACY.COM

86

 of 

98

(cid:160)

Item(cid:160)3.(cid:160) Quantitative and Qualitative Disclosures about Market Risk.
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)See Interest Rate Sensitivity in the Managements Discussion and Analysis of Financial
Condition and Results of Operations in Part(cid:160)I, Item(cid:160)2 for disclosures about market risk.

Item(cid:160)4.(cid:160)
Evaluation of Disclosure Controls and Procedures

Controls and Procedures

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)As of the end of the period covered by this report, the management of the Bank, under the
supervision and with the participation of the Banks Chief Executive Officer and Chief Financial
Officer, carried out an evaluation of the effectiveness of the Banks disclosure controls and
procedures as defined in Rule(cid:160)13a-15(e) of the Securities Exchange Act of 1934, as amended (the
Exchange Act). Based on that evaluation, the Chief Executive Officer and the Chief Financial
Officer concluded that the Banks disclosure controls and procedures were effective as of such date.

Changes in Internal Control over Financial Reporting

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)There was no change in the Banks internal control over financial reporting that occurred
during the period covered by this report that has materially affected, or is reasonably likely to
materially affect, the Banks internal control over financial reporting.

Part(cid:160)II. OTHER INFORMATION

Item 1.(cid:160)Legal Proceedings

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)In the ordinary course of business, we may be a party to various legal proceedings from time
to time. In the opinion of management, we are not a party to, nor is any of our property the
subject of, any pending or to our knowledge threatened proceeding, the outcome of which would
have a material impact on the Banks financial condition or results of operations.

Item(cid:160)1A(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Not applicable

Risk Factors

Item(cid:160)2.(cid:160) Unregistered Sales of Equity Securities and Use of Proceeds
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)During the three months ended September(cid:160)30, 2010, the Bank did not have any
unregistered sales of equity securities except as previously reported on the Banks Current Report
on Form 8-K dated August(cid:160)18, 2010 and did not have any repurchases of its common stock.

EX-99.1

POWERED BY DOCRACY.COM

87

 of 

98

Item(cid:160)3.(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Not applicable.

Defaults Upon Senior Securities

Item(cid:160)4.(cid:160)

[Removed and Reserved]

Item(cid:160)5.(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Not applicable.

Other Information

39

(cid:160)

Item(cid:160)6.(cid:160)
(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)The following documents are filed or furnished as exhibits to this report:

Exhibits

(cid:160)
(cid:160) (cid:160)
Exhibit (cid:160) (cid:160)
Number (cid:160) Description of Exhibits
1.1

(cid:160) Agreement and Plan of Reorganization and Share Exchange dated October(cid:160)22, 2010

by and between the Bank and Park Sterling Corporation, incorporated by reference
to Exhibit(cid:160)1.1 of the Banks Current Report on Form(cid:160)8-K dated October(cid:160)22, 2010

(cid:160)

(cid:160) (cid:160)

3.1(a)

(cid:160) Articles of Incorporation of the Bank, incorporated by reference to Exhibit(cid:160)3.1 of the

Banks Registration Statement on Form(cid:160)10

(cid:160)

(cid:160) (cid:160)

3.1(b)

(cid:160) Articles of Amendment to Articles of Incorporation of the Bank, incorporated by
reference to Exhibit(cid:160)3.1(b) of the Banks Quarterly Report on Form(cid:160)10-Q for the
quarter ended June 30, 2010

(cid:160)

(cid:160) (cid:160)

3.2(a)

(cid:160) Bylaws of the Bank, incorporated by reference to Exhibit(cid:160)3.2 of the Banks

Registration Statement on Form(cid:160)10

EX-99.1

POWERED BY DOCRACY.COM

88

 of 

98

(cid:160)

(cid:160) (cid:160)

3.2(b)

(cid:160) Amendment to the Bylaws of the Bank, incorporated by reference to Exhibit(cid:160)3.2 of

the Banks Current Report on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

10.1

(cid:160) Underwriting Agreement dated August(cid:160)12, 2010 between the Bank and Keefe,

Bruyette & Woods, Inc. as representative of the several underwriters, incorporated by
reference to Exhibit(cid:160)1.1 of the Banks Current Report on Form(cid:160)8-K dated
August(cid:160)18, 2010

(cid:160)

10.2

(cid:160) (cid:160)

(cid:160) Employment Agreement by and between James C. Cherry and the Bank effective
August(cid:160)18, 2010, incorporated by reference to Exhibit(cid:160)10.1 of the Banks Current
Report on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

10.3

(cid:160) Employment Agreement by and between Bryan F. Kennedy III and the Bank

effective August 18, 2010, incorporated by reference to Exhibit(cid:160)10.2 of the Banks
Current Report on Form 8-K dated August(cid:160)18, 2010

(cid:160)

10.4

(cid:160) (cid:160)

(cid:160) Employment Agreement by and between David L. Gaines and the Bank effective
August(cid:160)18, 2010, incorporated by reference to Exhibit(cid:160)10.3 of the Banks Current
Report on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

10.5

(cid:160) Park Sterling Bank Employee Stock Option Plan and related form of award

agreement, incorporated by reference to Exhibit(cid:160)10.5 of the Banks Current Report
on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

10.6

(cid:160) Park Sterling Bank Stock Option Plan for Directors and related form of award

agreement, incorporated by reference to Exhibit(cid:160)10.6 of the Banks Current Report
on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

31.1

(cid:160) Certification of Chief Executive Officer pursuant to Section(cid:160)302 of the

Sarbanes-Oxley Act of 2002

(cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

89

 of 

98

31.2

(cid:160) Certification of Chief Financial Officer pursuant to Section(cid:160)302 of the

Sarbanes-Oxley Act of 2002

40

(cid:160)

(cid:160)
(cid:160) (cid:160)
Exhibit (cid:160) (cid:160)
Number (cid:160) Description of Exhibits
32.1

(cid:160) Certification of Chief Executive Officer pursuant to Section(cid:160)906 of the

Sarbanes-Oxley Act of 2002

(cid:160)

(cid:160) (cid:160)

32.2

(cid:160) Certification of Chief Financial Officer pursuant to Section(cid:160)906 of the

Sarbanes-Oxley Act of 2002

41

(cid:160)
SIGNATURES

Under the requirements of the Securities Exchange Act of 1934, the Bank has duly caused this
report to be signed on its behalf by the undersigned thereunto duly authorized.

EX-99.1

POWERED BY DOCRACY.COM

90

 of 

98

(cid:160)
PARK STERLING
BANK
(cid:160)
By:(cid:160)(cid:160)

(cid:160)
(cid:160)

(cid:160)
By:(cid:160)(cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)

/s/ James C. Cherry (cid:160)

James C. Cherry(cid:160)
Chief Executive Officer (authorized
officer)(cid:160)

(cid:160)
/s/ David L. Gaines (cid:160)

David L. Gaines(cid:160)
Chief Financial Officer(cid:160)

(cid:160) (cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160)

(cid:160)
(cid:160)

(cid:160)
(cid:160)

Date: November 9,
2010(cid:160)
(cid:160)
(cid:160)

(cid:160)
(cid:160)
Date: November 9,
2010(cid:160)
(cid:160)
(cid:160)
42

(cid:160)
Exhibit Index

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160)

(cid:160) (cid:160)
(cid:160)
Exhibit (cid:160) (cid:160)
Number (cid:160) Description
1.1

(cid:160) Agreement and Plan of Reorganization and Share Exchange dated October(cid:160)22, 2010

by and between the Bank and Park Sterling Corporation, incorporated by reference
to Exhibit(cid:160)1.1 of the Banks Current Report on Form(cid:160)8-K dated October(cid:160)22, 2010

(cid:160)

(cid:160) (cid:160)

3.1(a)

(cid:160) Articles of Incorporation of the Bank, incorporated by reference to Exhibit(cid:160)3.1 of the

Banks Registration Statement on Form(cid:160)10

(cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

91

 of 

98

3.1(b)

(cid:160) Articles of Amendment to Articles of Incorporation of the Bank, incorporated by
reference to Exhibit(cid:160)3.1(b) of the Banks Quarterly Report on Form(cid:160)10-Q for the
quarter ended June 30, 2010

(cid:160)

(cid:160) (cid:160)

3.2(a)

(cid:160) Bylaws of the Bank, incorporated by reference to Exhibit(cid:160)3.2 of the Banks

Registration Statement on Form(cid:160)10

(cid:160)

(cid:160) (cid:160)

3.2(b)

(cid:160) Amendment to the Bylaws of the Bank, incorporated by reference to Exhibit(cid:160)3.2 of

the Banks Current Report on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

10.1

(cid:160) Underwriting Agreement dated August(cid:160)12, 2010 between the Bank and Keefe,

Bruyette & Woods, Inc. as representative of the several underwriters, incorporated by
reference to Exhibit(cid:160)1.1 of the Banks Current Report on Form(cid:160)8-K dated
August(cid:160)18, 2010

(cid:160)

10.2

(cid:160) (cid:160)

(cid:160) Employment Agreement by and between James C. Cherry and the Bank effective
August(cid:160)18, 2010, incorporated by reference to Exhibit(cid:160)10.1 of the Banks Current
Report on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

10.3

(cid:160) Employment Agreement by and between Bryan F. Kennedy III and the Bank

effective August(cid:160)18, 2010, incorporated by reference to Exhibit(cid:160)10.2 of the Banks
Current Report on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

10.4

(cid:160) (cid:160)

(cid:160) Employment Agreement by and between David L. Gaines and the Bank effective
August(cid:160)18, 2010, incorporated by reference to Exhibit(cid:160)10.3 of the Banks Current
Report on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

10.5

(cid:160) Park Sterling Bank Employee Stock Option Plan and related form of award

agreement, incorporated by reference to Exhibit(cid:160)10.5 of the Banks Current Report
on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

EX-99.1

POWERED BY DOCRACY.COM

92

 of 

98

10.6

(cid:160) Park Sterling Bank Stock Option Plan for Directors and related form of award

agreement, incorporated by reference to Exhibit(cid:160)10.6 of the Banks Current Report
on Form(cid:160)8-K dated August(cid:160)18, 2010

(cid:160)

(cid:160) (cid:160)

31.1

(cid:160) Certification of Chief Executive Officer pursuant to Section(cid:160)302 of the

Sarbanes-Oxley Act of 2002

(cid:160)

(cid:160) (cid:160)

31.2

(cid:160) Certification of Chief Financial Officer pursuant to Section(cid:160)302 of the

Sarbanes-Oxley Act of 2002

(cid:160)

(cid:160) (cid:160)

32.1

(cid:160) Certification of Chief Executive Officer pursuant to Section(cid:160)906 of the

Sarbanes-Oxley Act of 2002

43

(cid:160)

(cid:160) (cid:160)
(cid:160)
Exhibit (cid:160) (cid:160)
Number (cid:160) Description
32.2

(cid:160) Certification of Chief Financial Officer pursuant to Section(cid:160)906 of the

Sarbanes-Oxley Act of 2002

44

(cid:160)
Exhibit(cid:160)31.1

Certification of Chief Executive Officer
Pursuant to Section(cid:160)302 of the Sarbanes-Oxley Act of 2002

I, James C. Cherry, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Park Sterling Bank;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this
report;

3. Based on my knowledge, the financial statements, and other financial information included in

EX-99.1

POWERED BY DOCRACY.COM

93

 of 

98

this report, fairly present in all material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules(cid:160)13a-15(e) and 15d-15(e)) for
the registrant and have:

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(b) Intentionally omitted;

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(d) Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal
quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation
of internal control over financial reporting, to the registrants auditors and the audit committee of
the registrants board of directors (or persons performing the equivalent functions):

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(a) All significant deficiencies and material weaknesses in the design or operation of internal
control over financial reporting that are reasonably likely to adversely affect the registrants ability to
record, process, summarize and report financial information; and

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(b) Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.

(cid:160)
(cid:160)

Date: November 9, 2010(cid:160)
(cid:160)
45

(cid:160)

(cid:160)
PARK STERLING BANK
(cid:160)
/s/ JAMES C. CHERRY (cid:160)
James C. Cherry, Chief Executive Officer(cid:160)

(cid:160) (cid:160) (cid:160)
(cid:160)

(cid:160)
(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

94

 of 

98

(cid:160)
Exhibit(cid:160)31.2

(cid:160)

(cid:160)

(cid:160)

(cid:160)

Certification of Chief Financial Officer
Pursuant to Section(cid:160)302 of the Sarbanes-Oxley Act of 2002

I, David L. Gaines, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Park Sterling Bank;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or
omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this
report;

3. Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules(cid:160)13a-15(e) and 15d-15(e)) for
the registrant and have:

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(a) Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(b) Intentionally omitted;

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report based on such evaluation; and

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(d) Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal
quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation
of internal control over financial reporting, to the registrants auditors and the audit committee of
the registrants board of directors (or persons performing the equivalent functions):

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(a) All significant deficiencies and material weaknesses in the design or operation of internal

EX-99.1

POWERED BY DOCRACY.COM

95

 of 

98

control over financial reporting that are reasonably likely to adversely affect the registrants ability to
record, process, summarize and report financial information; and

(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(b) Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.

(cid:160)
(cid:160)

Date: November 9, 2010(cid:160)
(cid:160)
(cid:160)
46

(cid:160)

(cid:160)
Exhibit(cid:160)32.1

(cid:160)

(cid:160)
PARK STERLING BANK
(cid:160)
/s/ DAVID L. GAINES (cid:160)
David L. Gaines, Chief Financial Officer(cid:160)
(cid:160)

(cid:160) (cid:160) (cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160)

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Park Sterling Bank (the Bank) Quarterly Report on Form 10-Q for the
period ended September(cid:160)30, 2010 as filed with the Securities and Exchange Commission on the
date hereof (the Report), I, James C. Cherry, Chief Executive Officer of the Bank, certify pursuant
to 18 U.S.C. Section(cid:160)1350, as adopted pursuant to Section(cid:160)906 of the Sarbanes-Oxley Act of
2002, that:

(cid:160) (1) (cid:160) The Report fully complies with the requirements of Section 13(a) or 15(d) of the

Securities Exchange Act of 1934, as amended; and

(cid:160)
(cid:160) (2) (cid:160) The information contained in the Report fairly presents, in all material respects, the

financial condition and results of operations of the Bank.

EX-99.1

POWERED BY DOCRACY.COM

96

 of 

98

(cid:160)
(cid:160)

Date: November 9, 2010(cid:160)
(cid:160)
(cid:160)
47

(cid:160)

(cid:160)
Exhibit(cid:160)32.2

(cid:160)

(cid:160)
PARK STERLING BANK
(cid:160)
/s/ JAMES C. CHERRY (cid:160)
James C. Cherry(cid:160)
Chief Executive Officer(cid:160)

(cid:160) (cid:160) (cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)

(cid:160)

(cid:160)

(cid:160)

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Park Sterling Bank (the Bank) Quarterly Report on Form 10-Q for the
period ended September(cid:160)30, 2010 as filed with the Securities and Exchange Commission on the
date hereof (the Report), I, David L. Gaines, Chief Financial Officer of the Bank, certify pursuant
to 18 U.S.C. Section(cid:160)1350, as adopted pursuant to Section(cid:160)906 of the Sarbanes-Oxley Act of
2002, that:

(cid:160) (1) (cid:160) The Report fully complies with the requirements of Section 13(a) or 15(d) of the

Securities Exchange Act of 1934, as amended; and

(cid:160)
(cid:160) (2) (cid:160) The information contained in the Report fairly presents, in all material respects, the

financial condition and results of operations of the Bank.

(cid:160)
(cid:160)

Date: November 9, 2010(cid:160)
(cid:160)
(cid:160)

(cid:160)
PARK STERLING BANK
(cid:160)
/s/ DAVID L. GAINES (cid:160)
David L. Gaines(cid:160)
Chief Financial Officer(cid:160)

(cid:160) (cid:160) (cid:160)
(cid:160)

(cid:160)
(cid:160)
(cid:160)

EX-99.1

POWERED BY DOCRACY.COM

97

 of 

98

48

EX-99.1

POWERED BY DOCRACY.COM

98

 of 

98

